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Comprehensive whole exome sequencing in Japanese with young‐onset diabetes yields insights into their genetic background {#jdi12938-sec-0004}
------------------------------------------------------------------------------------------------------------------------

**D. Tanaka and N. Inagaki**

Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan

**Objective**: The aim of this study was to investigate the genetic background of Japanese with young‐onset diabetes using whole exome sequencing.

**Methods**: Eleven participants were diagnosed with glutamic acid decarboxylase \[GAD\]‐antibody negative diabetes under the age of 30, and they had never been obese (Body Mass Index \[BMI\] ≥ 25 kg/m^2^) before the diagnosis. Exome sequencing of their genome DNA was performed using the Agilent SureSelectXT Human All Exon V6 and an Illumina Hiseq sequencer. Then, non‐synonymous genetic variants that were rare (allele frequencies \<0.01) in the 1000 genomes and the Human Genetic Variation Database \[HGVD\] was selected and the functional deleteriousness of the variants was analyzed with the Combined Annotation Dependent Depletion \[CADD\].

**Results**: The average onset age of the 11 participants was 21.8 years, and their average BMI was 20.8 kg/m^2^. Six of the 11 participants were treated with insulin. We focused on rare non‐synonymous variants in 35 genes that were linked to monogenic diabetes, and we selected variants that were predicted to be functionally deleterious by CADD (CADD PHRED score \>20). As result, in one participant (\#1) p.V264 fs mutation in HNF1A gene was detected and the participant was diagnosed as maturity onset diabetes of the young type 3 (MODY3). The participant \#1 had no family history of diabetes. In another participant (\#2), p.G191D mutation in HNF1A gene and p.Q450H mutation in GLIS3 gene were detected and, in a participant \#3, p.K190del mutation in WFS1 gene was detected. The three mutations might underlie the pathogenesis of diabetes in the two participants (\#2, \#3). All the mutations mentioned above were heterozygous and in other eight participants no such deleterious mutations in the 35 genes were detected.

**Conclusion**: Comprehensive whole exome sequencing in subjects with young‐onset diabetes yielded insights into their genetic background
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Sodium orthovanadate and trigonella foenum graecum ameliorates cognitive deficits in alloxan‐induced diabetic rats {#jdi12938-sec-0006}
------------------------------------------------------------------------------------------------------------------

**P. Kumar and N. Baquer**

Jawaharlal Nehru University, New Delhi, India

**Objectives**: Diabetes is one of the leading causes of learning and memory deficits. In the present study, the effect of sodium orthovanadate (SOV) and Trigonella foenum graecum seed powder (TSP) administration has been studied on blood glucose and insulin levels, oxidative stress, inflammatory cytokines, learning and memory performances in hippocampus of the alloxan‐induced diabetic rats and to see whether the treatment with SOV and TSP is capable of reversing these effects.

**Materials and Methods**: Diabetes was induced by administration of alloxan monohydrate (15 mg/100gm b.wt.), and rats were treated with 2 IU insulin, 0.6 mg/ml SOV, 5% TSP in the diet and a combination of 0.2 mg/ml SOV with 5% TSP separately for 21 days. The learning and memory function were assessed by Morris water maze test. The oxidative stress indicators \[glutathione reductase (GRx), superoxide dismutase (SOD), neurolipofusicin and malondialdehyde (MDA)\] and inflammatory cytokines (TNF‐a, IL‐1β, and IL‐6) were measured in hippocampus using corresponding commercial kits. The mRNA and protein levels of PPARγ were evaluated by real‐time (RT)‐PCR and Western blot analysis.

**Results**: Diabetic rats showed hyperglycemia with almost four‐fold high blood glucose levels. Hyperglycemia increases lipid peroxidation and neurolipofusicin, causing decreased activities of antioxidant enzymes and learning and memory performances with diabetes in hippocampus. Rats treated with combined dose of SOV and TSP had glucose levels comparable to controls, similar results were obtained with the increased antioxidant enzymes levels, improved learning and memory performances, reduced MDA levels, significantly increased PPARγ expression, and alleviated TNF‐α, IL‐1β, and IL‐6 compared with the diabetic group in the hippocampus.

**Conclusions**: Our results showed that lower doses of vanadate (0.2 mg/ml) could be used in combination with Trigonella to effectively counter diabetic alterations without any toxic side effects. Therefore, combined therapy can indeed be considered a better alternative to be explored further as a means of diabetes‐associated cognitive decline control.
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The dynamic effects of maternal high‐fat diet on metabolic health and hepatic miRNAs expression in offspring mice with the aging {#jdi12938-sec-0008}
--------------------------------------------------------------------------------------------------------------------------------

**J. Chen and Z. Sun**

Medical School, Southeast University, Nanjing, China

**Objective**: Substantial studies demonstrated that maternal nutrition can significantly determine the susceptibility to developing some metabolic diseases in offspring. However, the dynamic effects of maternal high‐fat diet on metabolic health and miRNAs expression in offspring mice, such as from weaning to later life, have not been well documented.

**Materials and Methods**: We examined the effects on the offspring from dams were fed a normal chow (NC) diet or high‐fat (HF) diet during gestation and lactation. At weaning, the male offspring of dams fed on either a HF or NC and then weaned to either a HF or NC diet. Hepatic levels of miRNAs and target genes were investigated in the liver tissues of the offspring mice at 3 and 32 weeks old.

**Results**: Maternal HF diet feeding impaired metabolic health in offspring compared to controls. The blood glucose levels of the male offspring from the NC and HF dams weaned HF diet were significantly higher compared with control group. It showed that post‐weaning high‐fat diet could contribute to abnormal glucose metabolism in the later life of offspring. Microarray analysis indicated that expressions of miR‐615‐5p, miR‐3079‐5p, miR‐124\*, and miR‐101b\* were downregulated, whereas miR‐143\* was upregulated in livers from 3‐week old offspring. Microarray analysis indicated that expression of miR‐1948‐3p, miR‐409‐3p, miR‐592‐5p, miR‐127‐3p, miR‐541‐5p, miR‐149‐5p, miR‐344 g‐5p were downregulated, whereas miR‐1247‐5p and miR‐150‐5p were upregulated in livers from 32‐week‐old offspring from HF‐fed dams. Our functional enrichment analysis indicated that the target genes of these differentially expressed miRNAs were mapped to AMPK pathways. Activations of AMPK pathway can inhibit expressions of glucogenic genes, attenuate gluconeogenic program, promote mitochondrial biogenesis and increase free fatty acid oxidation.

**Conclusions**: Our result showed that offspring fed with high‐fat diet had heavier body weight, severer impaired glucose tolerance and lower insulin sensitivity level at 32 weeks of age. Furthermore, hepatic miRNAs expression is dynamically changed along with the aging of offspring. Thus, dynamic hepatic miRNAs expression may be the underlying mechanism between early life nutrition and metabolic health in offspring.
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Gut hormone responses to mixed meal test in new‐onset prediabetes and diabetes after acute pancreatitis {#jdi12938-sec-0010}
-------------------------------------------------------------------------------------------------------

**S. A. Pendharkar, R. G. Singh, A. Cervantes, S. V. DeSouza, S. H. Bharmal and M. S. Petrov**

University of Auckland, Auckland, New Zealand

**Purpose**: Significant broadening of therapeutic options in the setting of type 2 diabetes over the last decade has been driven by enhanced understanding of gut. Gut has been implicated in pathogenesis of diabetes since 1930s, with ensuing decades seeing the discovery of gut hormones such as gastric inhibitory peptide, glucagon‐like peptide‐1, oxyntomodulin, and peptide YY. Although altered gut hormone response in subtypes of diabetes of the exocrine pancreas has previously been reported, results are conflicting. Also, no study has investigated gut hormone responses to nutrients in the setting of new‐onset prediabetes/diabetes after acute pancreatitis. The study aims to investigate gut hormone responses to mixed meal test in individuals with new‐onset prediabetes/diabetes after acute pancreatitis (cases) compared to healthy controls, and the effect of body fat parameters.

**Methods**: 29 cases and 29 age‐ and sex‐matched healthy controls were recruited. All participants were given a 12 oz. Boost^®^ drink, and blood samples were collected before and after stimulation to measure DPP‐IV, gastric inhibitory peptide, glucagon‐like peptide‐1, insulin, oxyntomodulin, and peptide YY. Body fat parameters were measured using magnetic resonance imaging. Indices of insulin sensitivity and insulin secretion were calculated. Repeated measures and linear regression analyses were conducted in unadjusted and adjusted models.

**Results**: Gastric inhibitory peptide levels were significantly higher whereas oxyntomodulin levels were significantly lower in cases compared to controls in both the unadjusted (*P* \< 0.001 and *P* \< 0.001, respectively) and adjusted (*P* \< 0.001 and *P* \< 0.001, respectively) models. In cases, liver fat % and BMI contributed up to 13.4% (vs 2.9% controls) and 20.8% (vs 9.9% in controls) to variance in circulating gastric inhibitory peptide and oxyntomodulin levels, respectively.

**Conclusion**: New‐onset prediabetes and diabetes after acute pancreatitis appears to be characterised by increased secretion of gastric inhibitory peptide, and decreased secretion of oxyntomodulin. Further, liver fat % and BMI appear to be the body fat parameters that contribute most significantly to gastric inhibitory peptide and oxyntomodulin levels.
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Association between cystatin c and subclinical atherosclerosis in patients with diabetes type 2 and chronic kidney disease {#jdi12938-sec-0012}
--------------------------------------------------------------------------------------------------------------------------

**V. Vasilkova^1^, T. Mokhort^2^, E. Naumenko^3^ and N. Filiptsova^3^**

^1^Gomel State Medical University, Gomel, Belarus, ^2^Belarusian State Medical University, Minsk, Belarus, ^3^The Republican Research Center for Radiation Medicine and Human Ecology, Gomel, Belarus

**Objective**: Cystatin C (CysC) has been found to be an independent risk factor for cardiovascular disease. We aimed to evaluate the possible association between CysC and subclinical atherosclerosis in patients with type 2 diabetes (DT2) and chronic kidney disease (CKD).

**Methods**: We selected 200 patients both sexes with DT2 and CKD aged 63.84 ± 9.03 (25--80) years. Control group included 84 healthy subjects the same age. The intima‐media thickness (IMT) was measured as the distance between the lumen‐intima interface and the media‐adventitia interface. Atherosclerotic plaque was defined as a focal structure encroaching into the arterial lumen of 0.5 mm or 50% of the surrounding IMT value. Total plaque area (TPA) was calculated as the sum of all plaque areas. GFR was estimated using the modification of diet in renal disease (MDRD) equation.

**Results**: Patients were divided into 3 groups by CysC levels tertiles. Patients in the high CysC tertile had significantly higher mean cIMT (*P* = 0.03), and TPA (*P* = 0.02) compared to patients in the lower tertiles. CysC levels demonstrated significant positive correlation with the mean cIMT (r = 0.45, *P* = 0.011) and TPA (r = 0.37, *P* = 0.03). In multivariate logistic analyses adjusted for cardiovascular risk factors, the association between CysC and IMT remained significant (OR: 2.59, 95% CI: 1.06--6.33, *P* = 0.04). In contrast, neither serum creatinine nor estimated GFR was associated with IMT (OR: 0.88, 95% CI: 0.78--1.00, *P* = 0.06, OR: 0.96, 95% CI: 0.89--1.04, *P* = 0.30, respectively). A receiver operating characteristic curve analysis validates the diagnostic accuracy of CysC for cIMT. At a 1.01 mg/L Cystatin C cut‐off point, the sensitivity and specificity for increased cIMT were 84% and 78%, respectively (c‐statistic 0.81, 95% CI 0.71--0.90, *P* \< 0.001).

**Conclusions**: Our study demonstrated a significant association of increased CysC levels with characteristics of carotid atherosclerosis in patients with DT2 and CKD.
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Meta‐analysis of genome‐wide association studies identifies novel genetic variants associated with diabetic kidney disease among Chinese patients with type 2 diabetes {#jdi12938-sec-0014}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------

**G. Jiang^1^, C. H. Tam^1^, A. O. Luk^1^, H. M. Lee^1^, C. K. Lim^1^, R. Ozaki^1^, S. K. Tsui^1^, Y. Huang^1^, H. Y. Lan^1^, W. Yu^2^, K. F. Lee^3^, S. C. Siu^4^, G. Hui^4^, C. C. Tsang^5^, K. P. Lau^6^, J. Lee^7^, M. W. Tsang^8^, G. Kam^8^, I. T. Lau^9^, J. K. Li^10^, V. T. Yeung^11^, S. Fung^12^, S. Lo^13^, E. Lau^13^, Y. L. Cheng^14^, C. C. Chow^1^, S. Lok^15^, T. F. Chan^1^, K. Yip^1^, X. Fan^1^, N. Tang^1^, B. Tomlinson^1^, C. C. Szeto^1^, W. Y. So^1^, J. C. Chan^1,16^, R. C. Ma^1,16^, Hong Kong Diabetes Register, Hong Kong Diabetes Biobank and TRANSCEND Consortium**

^1^The Chinese University of Hong Kong, Hong Kong, China, ^2^Hong Kong University of Science and Technology, Hong Kong, China, ^3^Kwong Wah Hospital, Hong Kong, China, ^4^Tung Wah Eastern Hospital, Hong Kong, China, ^5^Alice Ho Miu Ling Nethersole Hospital, Hong Kong, China, ^6^North District Hospital, Hong Kong, China, ^7^Ruttonjee Hospital, Hong Kong, China, ^8^United Christian Hospital, Hong Kong, China, ^9^Tseung Kwan O Hospital, Hong Kong, China, ^10^Yan Chai Hospital, Hong Kong, China, ^11^Our Lady of Maryknoll Hospital, Hong Kong, China, ^12^Princess Margaret Hospital, Hong Kong, China, ^13^Pamela Youde Hospital Nethersole Eastern Hospital, Hong Kong, China, ^14^Alice Ho Miu Ling Nethersole Hospital, Hong Kong, China, ^15^The Hospital for Sick Children, Toronto, Canada, ^16^CUHK‐SJTU Joint Research Centre on Diabetes Genomics and Precision Medicine, Hong Kong, China

Diabetic kidney disease (DKD) is a leading cause of morbidity and mortality in patients with type 2 diabetes (T2D) worldwide. However, the genetic basis of DKD remains poorly understood. In this project, we utilize a trans‐omic approach to investigate the genome, epigenome, and transcriptome of patients with diabetic kidney disease. We performed a meta‐analysis of genome‐wide association study using data generated from the Hong Kong Diabetes Register (HKDR) and the Hong Kong Diabetes Biobank (HKDB). DKD was defined as micro‐ or macro‐albuminuria, or end‐stage renal disease (defined as dialysis or transplant, or eGFR \<15 ml/min/1.73 m^2^). eGFR was calculated according to the Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) equation. We have examined a total of 5191 cases with DKD, and 2793 controls with duration of T2D ≥ 10 years and free from proteinuria and end‐stage renal disease. DNA samples were genotyped using the Illumina HumanOmni2.5Exome‐8 BeadChip and the Illumina Infinium^®^ Global Screening Array (GSA) in HKDR and HKDB studies, respectively. We imputed the genotypes using minimac 3, with 1000 genome project phase III data as reference panel. Within gender, ˜6.6 million high‐quality common variants (MAF ≥ 1%) were included in logistic regression model, adjusting for age and principal components. Results of sex‐specific association in the two studies were combined by meta‐analysis. A total of 77 variants were associated with DKD at threshold of *P* \< 10^−5^ from 12 distinct genomic regions on chromosomes 2, 3, 6, 7, 8, 9 and 13. The strongest signal was from a SNP located at 7p14.3 (OR = 1.20 \[95% CI: 1.12--1.28\], *P* = 1.5×10^−7^). This variant was also identified to be associated with micro‐albuminuria (3895 cases versus 2836 controls with duration of T2D ≥ 10 years and free from proteinuria; *P* = 1.2×10^−6^). Our study has identified a number of novel regions associated with diabetic kidney disease. Replication studies and extension of these findings are currently in progress.
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Liraglutide improves nonalcoholic fatty liver disease (NAFLD) via MiR‐124a/ATGL/Sirt1 pathway {#jdi12938-sec-0016}
---------------------------------------------------------------------------------------------

**C. Li**

Tianjin Metabolic Diseases Hospital & Tianjin Institute of Endocrinology

**Aims**: Liraglutide has been shown to attenuate hepatocyte steatosis, but the specific underlying mechanism remains unknown. ATGL, a newfound hepatic lipase, has been seen as a crucial regulator in hepatic lipid homeostasis by accumulated studies. Our study was to further elucidate an underlying mechanism by which liraglutide prevents NAFLD via regulating ATGL expression from miRNA perspective.

**Methods**: Protein expression was evaluated by Western Blot. miRNA expression was evaluated by TaqMan miRNA assay. Immunofluorescence was used to detect ATGL expression in different groups in vivo. Luciferase was done to validate regulation of ATGL by liraglutide via miR‐124a. Oil red O staining was used to check lipid content. Overexpressing or inhibiting the physiological role of miR‐125b in the Human liver cells (HLs) through transfecting miR‐124a inhibitor, miR‐124a mimics were used to identify the function of miR‐124a in vitro.

**Results**: After 8 weeks of liraglutide treatment, we found that lipid deposition and inflammation were improved dramatically in the liver of male WT mice challenged with a high‐fat diet (HFD). In addition, the protein expression of ATGL and SIRT1 was upregulated, whereas the inflammatory cytokines aggregating nonalcoholic fatty liver disease (NAFLD) progression such as interleukin‐1b (IL‐1β), tumor necrosis factor alpha‐α (TNF‐α), and nuclear factor‐kB (NF‐kB) were downregulated in the HFD group after liraglutide treatment. In Human Liver cells (HLs) incubated in high‐fat (0.1 mM palmitate: PA) medium, liraglutide ameliorated intracellular lipid accumulation and above inflammatory cytokines as well as upregulated ATGL and Sirt1 protein expressions. Using bioinformatic analyses, we further identified that ATGL is the direct target of miR‐124a. MiR‐124a levels were increased under high‐fat situation but reduced after treatment of liraglutide. In addition, miR‐124a mimics aggravated the intracellular lipid content and inflammation in HLs cultured in high‐fat situation, while miR‐124a inhibitor reversed this trend and imitated the protective effects of liraglutide on hepatocytes.

**Conclusion**: Our data demonstrated that liraglutide upregulated ATGL and Sirt1 protein expressions through downregulating miR‐124a expression to alleviate hepatic steatosis and inflammation, suggesting that GLP‐1 receptor agonist could serve as a potential drug for NAFLD.
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A porcine placental extract ameliorates lipotoxicity‐induced NASH by polarizing M2 macrophages and attenuating stellate cell activation {#jdi12938-sec-0018}
---------------------------------------------------------------------------------------------------------------------------------------

**T. Ota^1^, G. Chen^2^ and L. Xu^2^**

^1^Asahikawa Medical University, Asahikawa, Japan, ^2^Kanazawa University, Kanazawa, Japan

**Objective**: Excessive hepatic lipid accumulation causes oxidative stress and promotes the activation of macrophage/Kupffer cells, resulting in exacerbation of insulin resistance and nonalcoholic steatohepatitis (NASH). Placental extracts have been used to treat various chronic diseases due to their anti‐oxidative effect. However, the effects of the placental extracts on the development of NASH have yet to be elucidated. Here, we investigated the effect of porcine placental extract (PPE) in a lipotoxicity‐induced NASH model.

**Methods**: C57BL/6 mice were fed on a high‐cholesterol and high‐fat (CL) diet or a CL diet containing 0.3% PPE (CL + PPE) for 15 weeks. Liver histology and fibrogenesis were examined. Intrahepatic immune cell numbers were quantified by flow cytometry.

**Results**: The PPE significantly attenuated hepatic steatosis, and the increase in liver triglyceride (TG) and TBARS levels caused by the CL diet. The PPE improved glucose intolerance and enhanced the insulin signal, assessed by IRβ and Akt phosphorylation in the liver, which was associated with the attenuation of MAPK (ERK/p38MAPK) and NF‐κB activation. In addition, the PPE reduced the number of CD11c^+^ CD206^‐^M1 liver macrophages by 44.2%, but increased the number of CD11c^‐^CD206^+^M2 macrophages by 1.4‐fold, resulting in a predominance of M2 over M1 macrophage populations in the liver of NASH mice. Accordingly, the PPE suppressed lipopolysaccharide‐induced M1 polarization in isolated murine peritoneal macrophages, whereas it facilitated interleukin 4‐induced M2 polarization. Furthermore, the PPE reduced the hepatic stellate cell (HSC) activation associated with the attenuated transforming growth factor‐β/Smad3 signaling, both in the liver of NASH mice and in RI‐T cells, a HSC line.

**Conclusions**: The PPE alleviates lipotoxicity‐induced NASH by polarizing M2 macrophages and attenuating stellate cell activation in mice. Thus, PPE may be a potential approach to prevent NASH.

OP‐9 {#jdi12938-sec-0019}
====

Short‐chain fatty acids ameliorate diabetic nephropathy via GPR43‐mediated inactivation of NF‐κB signaling {#jdi12938-sec-0020}
----------------------------------------------------------------------------------------------------------

**W. Huang, J. Gu, L. Zhou and Y. Xu**

Affiliated Hospital of Southwest Medical University, Luzhou, China

**Objective**: Diabetic nephropathy (DN) is a serious microvascular complication of diabetes. It has been well known that the activation of nuclear factor kappa B (NF‐κB) inflammatory signaling plays an important role in the pathogenesis of DN. Recently, short‐chain fatty acids (SCFAs) produced from carbohydrate fermentation in gastrointestinal tract have emerged as new therapeutic targets of kidney diseases via combination with G protein coupled receptors (GPCRs) or inhibiting intracellular HDACs enzyme. However, it is unclear whether SCFAs might prevent and ameliorate DN.

**Methods**: High‐fat diet (HFD) and streptozotocin (STZ)‐induced T2D mouse were intraperitoneally injected (100 mg/(kg·48 h)) with three main SCFAs (acetate, propionate, and butyrate), for 12 weeks, blood glucose level, insulin resistance, renal injury and inflammation were assessed in vivo. High glucose‐induced mouse glomerular mesangial cells (GMCs) in vitro, SCFAs or GPR43 agonist were used as intervention, GPR43 was over‐expressed or suppressed by transfection with a GPR43 expressing vector or siRNA‐GPR43 in GMCs, respectively, important components of oxidative stress and NF‐κB signaling were detected to evaluated the role and possible molecular mechanism of these SCFAs.

**Results**: Exogenous SCFAs administration, especially butyrate, improved the hyperglycemia level and insulin resistance, prevented the renal dysfunction and renal injury, modulated the expression of GPR43 and β‐arrestin‐2 in vivo. SCFAs inhibited high glucose‐induced oxidative stress and NF‐κB signaling activation in GMCs. And SCFAs‐mediated benefit effects were significantly facilitated by over‐expression GPR43 or imitated by GPR43 agonist, but which were inhibited by siRNA‐GPR43. Specifically, co‐IP revealed that intracellular β‐arrestin‐2 and I‐κBα were able to form a complex in GMCs, butyrate enhanced the interaction between β‐arrestin‐2 and I‐κBα via GPR43.

**Conclusion**: These results support the conclusion that SCFAs, especially butyrate, partially improve T2D‐induced kidney injury, and inhibited high glucose‐induced NF‐κB inflammatory signaling. The protective effects of SCFAs against diabetic renal injury may be due to activating GPR43 and increasing the interaction between β‐arrestin2 and I‐κBα, suggesting a potential molecular mechanism for SCFAs‐inhibited NF‐κB activation in the treatment of DN.
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Glycine suppressed AGEs formation and subsequent RAGE‐Nox‐NF‐κB signaling pathway by restoring both GSH synthesis and Glo1 function in HUVECs {#jdi12938-sec-0022}
---------------------------------------------------------------------------------------------------------------------------------------------

**Z. Wang, J. Zhang, L. Chen, J. Li and X. Guo**

Peking University First Hospital, Beijing, China

The accumulation of advanced glycation endproducts (AGEs) can activate the receptor of AGEs (RAGE) and induce sustained oxidative stress, thus underlying diabetic macrovascular complications. Extensive studies have found that glyoxalase‐1 (Glo1), and its cofactor glutathione (GSH) could inhibit AGEs formation by promoting the degradation of methylglyoxal (MG), the major precursor of AGEs. Glycine is a crucial substrate of glutathione synthesis. The beneficial effects of glycine in improving vascular relaxation and attenuating lens glycation have been reported, but the mechanisms remain unclear. In this study, we aimed to investigate the effects of glycine on the Glo1 function and the AGE/RAGE axis in human umbilical vascular endothelial cell line (HUVEC), in an effort to explore possible mechanisms. The HUVECs were incubated with 400 μM MG and co‐treated with different concentration of glycine (0.5 mM, 2 mM, 4 mM) for 72 h. The GSH/GSSG ratios as well as the expression and the activity of Glo1 were measured before and after glycine treatment. Alterations of viability, the generation of reactive oxygen species (ROS), the formation of AGEs and the expressions of RAGE, Nox4 and NF‐κB p65 were determined.

The viability dropped 30% after 72 h of MG treatment, but was elevated after 2 mM and 4 mM glycine treatment. In MG‐treated HUVECs, the expression and activity of Glo‐1 and the GSH/GSSG ratios were markedly decreased but were significantly restored by 4 mM glycine treatment. In this manner, the increased AGEs formation in cells treated with MG was decreased by 4 mM glycine treatment. Administration of 2 mM and 4 mM glycine significantly suppressed the expression of RAGE, Nox4 and NF‐κB p65, and the ROS generation was also inhibited. Our results indicated that glycine might work by promoting GSH synthesis and enhancing Glo‐1 function to suppress AGEs formation and the activation of RAGE axis, thus protecting HUVECs against the deleterious glycation effects of MG.
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Normalization of insulin resistance, glucose intolerance and lipid profile by Swieteniamahagoni (L.) Jacq.leaf extract in fructose‐induced diabetic rats {#jdi12938-sec-0024}
--------------------------------------------------------------------------------------------------------------------------------------------------------

**Y. P. Naveen^1,2^, A. Urooj^1^ and J. B. Chauhan^2^**

^1^Department of Studies in Food Science and Nutrition, University of Mysore, Mysore, Karnataka, India^2^Department of Biochemistry, Pooja Bhagavath Memorial Mahajana PG Center, Mysuru, Karnataka, India

**Ethnopharmacological relevance**: Swietenia mahagoni (L.) Jacq. is a medicinal plant used in traditional medicinal practices for the treatment of various human ailments. The plant has been shown to possess potent pharmacological value in our previous studies. The present study is an extension of anti‐diabetic study in type 2 diabetic model.

**Materials and Methods**: Present study evaluates the anti‐diabetic potential of Swietenia mahagoni (L.) Jacq. aqueous extract (MAE) in fructose‐induced diabetic rats with insulin resistance. Insulin resistance was induced in Wistar rats by feeding fructose (20 % W/V) for 8 week. After the confirmation of insulin resistance induction, the rats were treated with MAE for 45 days and the effect of treatment on the diabetes pathology was continuously assessed. MAE was analyzed using HPLC and LCMS for identification of constituent bio‐actives present.

**Results**: MAE treatment improved glucose levels by 64.10 %), reduced the insulin levels by 27.56 % insulin resistance by 58.2 %, improved oral glucose tolerance, improved pancreatic β‐cell health by 29.5 %, decreased glycated hemoglobin content by 23.28 %, reduced lipid peroxides, improved glycogen content by 21.8 %, overall improvement in antioxidant status and improved lipid profile in treated group when compared to diabetic control group. The HPLC analysis indicated the presence of gallic acid, scopoletin, coumarin, epicatechin and ellagic acid, and their presence was confirmed by LCMS analysis.

**Conclusion**: Results supported the anti‐diabetic potential of MAE in type 2 diabetic model, where it acts on multi‐targets and ameliorate the overall diabetic condition rather only targeting to control hyperglycemia. Thus, the study supports the scope of Swietenia mahagoni (L.) Jacqas a potential candidate which can be studied as adjuvant in Type 2 diabetic subjects.
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ADSSL1 regulates UCP1 expression in beige adipocytes {#jdi12938-sec-0026}
----------------------------------------------------

**S. Chen, M. Alimujiang, N. Bai, Q. Fang, Y. Yang and W. Jia**

Shanghai Key Laboratory of Diabetes, Shanghai Institute for Diabetes, Shanghai Clinical Medical Centre of Diabetes, Shanghai Key Clinical Centre of Metabolic Diseases, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, China

Promoting white adipose tissue (WAT) browning may be a therapeutic strategy to combat obesity and its complications. Previous studies have reported that the purine metabolic pathways of psychrophiles tend to be enriched with de novo AMP synthetic enzymes. Cold exposure is a classical treatment to promote browning of WAT. At present, there are no studies have reported the expression changes and functional mechanisms of AMP de novo synthesis‐related enzymes during WAT browning. Here, our study found that the expression of ADSSL1 was increased during cold exposure induced WAT browning. Moreover, ADSSL1 was the only one among the AMP de novo synthesis‐related enzymes that the expression was increased during this process, and there was no change in the expression of other de novo synthesis‐related enzymes. To investigate the possible biological role of ADSSL1, we isolated SVFs from the inguinal WAT of C57BL/6 mice and induced into fully differentiated beige adipocytes. We found that ADSSL1 expression was increased during beige adipocytes differentiation, in parallel with the induction of UCP1 and PPARγ. The SVFs were infected with corresponding lentivirus to mediate ADSSL1 knockdown and overexpression. The results showed that the ADSSL1 gene knockdown and overexpression did not affect the differentiation and lipid synthesis of beige adipocytes. We then examined the key thermogenic gene UCP1 and found that its expression was increased in the case of ADSSL1 knockdown and decreased in the case of ADSSL1 overexpression. HPLC method was then used to detect intracellular AMP, ADP and ATP concentrations. We found that intracellular AMP, ADP and ATP levels were decreased in the state of ADSSL1 knockdown and increased in the state of ADSSL1 overexpression. It is worth noting that the AMP/ATP ratio was decreased in the state of ADSSL1 knockdown and increased in the state of ADSSL1 overexpression. We further examined the enzyme activity of AMPK and found that the phosphorylation level of AMPK increased in the state of ADSSL1 knockdown and decreased in the state of ADSSL1 overexpression. Overall, our finding reveals the biological roles of ADSSL1 in regulating UCP1 expression by influencing AMP synthesis and AMPK activity in beige adipocytes.

OP‐13 {#jdi12938-sec-0027}
=====

Fibroblast growth factor 21 maintains insulin sensitivity through specific expansion of subcutaneous adipose tissue {#jdi12938-sec-0028}
-------------------------------------------------------------------------------------------------------------------

**H. Li^1^, L. Wu^1^, Q. Fang^1^, A. Xu^2^ and W. Jia^1^**

^1^Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, China^2^The Univerisity of Hong Kong, Hong Kong, China

**Background**: Fibroblast growth factor 21 (FGF21) has recently attracted great attention due to its multiple therapeutic benefits against obesity‐related medical complications. Despite its multiple benefits, FGF21 is paradoxically elevated in obesity and diabetes in both animals and humans. Although the pharmacological effects of FGF21 are well‐documented, uncertainty about its role in regulating excessive energy intake remains.

**Method**: FGF21 knockout mice (FGF21KO) were used for this study. Klb AdipoKO mice were generated by crossing the βklotho gene floxed mice with adiponectin Cre mice. To mimic the physiologically‐relevant HFD‐induced FGF21 level, FGF21KO mice were implanted with osmotic pumps on the back, slightly posterior to the scapulae to continuously deliver rmFGF21 for 4 weeks (0.1 mg/kg/day). Subcutaneous fat transplantation was performed to study the role of subcutaneous fat. Result

We show that FGF21 improves systemic insulin sensitivity by promoting the healthy expansion of subcutaneous adipose tissue (SAT). Serum FGF21 levels positively correlate with the SAT area in insulin‐sensitive obese individuals. FGF21KO and Klb AdipoKO mice show less SAT mass and are more insulin‐resistant when fed a high‐fat diet. Replenishment of recombinant FGF21 to a level equivalent to that in obesity restores SAT mass and reverses insulin resistance in FGF21KO, but not in adipose‐specific βklotho knockout mice. Moreover, transplantation of SAT from wild‐type to FGF21KO improves insulin sensitivity in the recipient mice. Mechanistically, circulating FGF21 upregulates adiponectin in SAT, accompanied by an increase of M2 macrophage polarization.

**Conclusion**: Such an adipose‐specific action of FGF21 is attributed to high level of expression of the FGF21 receptor complex. FGF21 upregulates adiponectin in subcutaneous fat, consistent with an increase of M2 macrophage polarization in the subcutaneous adipocytes and the following anti‐inflammatory change. These factors maintain systemic insulin sensitivity. Elevated endogenous FGF21 in response to dietary‐induced obesity serves as a defense mechanism against systemic insulin resistance.
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Role of sphingosine kinase in insulin signaling and its action in hepatocytes {#jdi12938-sec-0030}
-----------------------------------------------------------------------------

**N. M. Li^1,2^ and P. Xia^2^**

^1^Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM), Malaysia^2^Centenary Institute, Sydney Medical School, University of Sydney, Australia

**Background and aims**: Sphingosine kinase (SK) is a key enzyme involves in the homeostasis of sphingolipids metabolism by catalyzing phosphorylation of sphingosine to sphingosine 1‐phosphate (S1P). Increased level of sphingolipids is associated with insulin resistance. In this study, we aimed to examine the potential role of SK in insulin signaling and its metabolic actions in hepatocytes.

**Methodology**: A human hepatocarcinoma cell line (Huh7), a nonneoplastic human hepatic cell line (PH5CH8) and freshly isolated mouse primary hepatocytes from wild‐type (WT) or SK1 knockout (SK1^−/−^) were used as experimental models. SK expression and activity were manipulated by gene overexpression of WT or dominant‐negative SK, siRNA‐mediated knockdown, and using a specific chemical inhibitor, SKI‐II.

**Findings**: Treatment of hepatocytes with insulin resulted in twofold increase in SK enzyme activity. Inhibition of SK activity by overexpressing a dominant‐negative mutant (SKG82D) or the enzyme inhibitor SKI‐II significantly attenuated insulin‐induced Akt activation, while overexpression of WT‐SK markedly enhanced Akt activation. Inhibition of SK activity markedly inhibited the association of IRS‐1 with p85 regulatory subunit of PI3‐K, suggesting a molecular target for *Figure 1*. Proposed model molecular mechanism of SphK2 action to enhance the action of SK on insulin signaling. Interestingly, we revealed that SK2 insulin‐mediated glucose metabolic actions in the hepatocytes were predominantly insoform for insulin‐induced Akt activation in hepatocytes. Insulin‐induced Akt activation and phosphorylation of two important Akt downstream targets GSK3α and 70S6K were significantly attenuated in the hepatocytes where SK2 was knocked down by its specific siRNA. Insulin‐induced suppression of 1 phosphoenolpyruvate carboxykinase (PEPCK) gene, a rate‐limiting enzyme in gluconeogenesis, was abolished by knockdown of SK2 expression. In contrast, the siRNA‐mediated knockdown of SK1 expression had no significant effects on insulin‐induced Akt activation ^2.^ and PEPCK suppression, indicating an isoform‐specific effect of SK2 on insulin action in hepatocytes.

**Conclusion**: Our data suggest a potential role of SK2 in regulation of insulin signaling and glucose metabolic action in hepatocytes.
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Monogenic obesity mutations lead to less weight loss afer bariatric surgery: a 6‐year follow‐up study {#jdi12938-sec-0032}
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**Y. Li and C. Hu**

Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Hypothalamic arcuate nucleus, a neural centre for energy balance, plays an important role in metabolic homeostasis. However, the influence of mutations in genes related to the feeding centre on weight loss after bariatric surgery is still unclear. We investigated the prevalence of monogenic obesity in obese subjects who underwent bariatric surgery and then evaluated the association between these mutations and weight loss after bariatric surgery. The proportion of obese adults with one mutation was as high as to 8.4%, some genes with mutations included *LEP, LEPR, MC4R, MC3R, SIM1 and PCSK1*. Weight loss for the majority of these individuals would peak at 1 to 2 years after surgery and then decrease in subsequent years. Nevertheless, mutation carriers had less weight loss over both short‐term and long‐term periods. Survival analyses indicated that it was harder to attain the goal of 20% weight loss for mutation carriers (Plog‐rank = 0.001; Pbreslow\<0.001), and the difference remained significant after adjusting for age, gender, and BMI at baseline with a Cox regression model. In conclusion, our data indicated that 8.4% of obesity cases were caused by change in genetics, and mutations in genes associated with the feeding centre had negative effects on the efficacy of bariatric surgery.
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The FGF21 mRNA expression was correlated with fasting blood glucose in the human visceral adipose tissue {#jdi12938-sec-0034}
--------------------------------------------------------------------------------------------------------
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**Background**: The *FGF21* is a well‐known mitokine to affect systemic energy metabolism. We investigated *FGF21* mRNA expression in adipose tissue associated with glucose homeostasis.

**Methods**: We obtained omental adipose tissue from 32 females with normal glucose tolerance (*n* = 16) or impaired fasting glucose (*n* = 14) or diabetes mellitus (*n* = 2) undergoing gynecologic surgery. We examined the mRNA expression of *FGF21* in visceral adipose tissue using quantitative RT‐PCR and performed correlation analysis of this expression with the clinical characteristics of the subjects.

**Results**: The mean age of study subjects was 46.7 ± 5.6 years old, and mean body mass index (BMI) was 25.6 ± 2.8 kg/m^2^. The *FGF21* mRNA level was significantly correlated with fasting blood glucose (r = 0.406, *P* = 0.023), but not with age (r = 0.133, *P* = 0.476) or BMI (r = 0.186, *P* = 0.316).

**Conclusion**: The *FGF21* mRNA expression of human visceral adipose tissue was positively correlated with fasting blood glucose.
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Linagliptin suppresses the progression of atherosclerosis in high‐fat‐fed apoE‐deficient mice via inactivation of macrophages {#jdi12938-sec-0036}
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**S. Nishida, T. Matsumura, S. Murakami‐Nishida, T. Senokuchi, N. Ishii, S. Yamada, Y. Morita, H. Motoshima, T. Kondo and E. Araki**

Department of Metabolic Medicine, Kumamoto University Faculty of Life Sciences, Kumamoto, Japan

**Background**: Patients with type 2 diabetes (T2D) often suffer from cardiovascular events. Dipeptidyl peptidase‐4 (DPP‐4) inhibitors suppressed the progression of atherosclerosis in atherosclerotic mouse models. However, clinical studies revealed that DPP‐4 inhibitors did not reduce primary composite cardiovascular events in T2D. Since linagliptin, one of the DPP‐4 inhibitors, has anti‐oxidative effect via its xanthine structure, it is possible that linagliptin has additive anti‐atherosclerotic effects. In this study, we investigate whether linagliptin suppresses progression of atherosclerosis in *high fat diet‐fed* apolipoprotein‐E ‐deficient (ApoE KO) mice via antioxidative effect on macrophages.

**Methods**: ApoE KO mice were fed with high‐fat diet and treated orally with linagliptin (10 mg/kg/day) (*n* = 8) or vehicle alone (water) as a control (*n* = 8). After 8 weeks of treatment, the mice were sacrificed and the whole aorta or 6‐μm‐thick frozen sections of the aortic sinus were stained with Oil red O, or anti‐4‐HNE and anti‐F4/80 antibodies. Plasma lipid profiles were measured at Skylight Biotech Inc., (Akita, Japan). Mouse peritoneal macrophages were used in *in vitro* study. Expression of MCP‐1 and TNF‐α mRNA was evaluated by real‐time RT‐PCR. Intracellular ROS generation was evaluated by H2DCF‐DA assay.

**Results**: There were no significant differences on dietary intake, body weight, casual blood glucose and glucose levels upon food‐load test between control group and linagliptin group. However, cholesterol concentrations in chylomicron, VLDL and LDL particle were lower in linagliptin group. Oil Red O staining of aortic sinus and whole *aorta* demonstrated that size of atherosclerotic lesions was decreased in linagliptin group than in control group. The 4‐HNE‐positive area and number of macrophages in plaques were decreased, and mRNA expression of MCP‐1 and TNF‐α in the aorta was lower in linagliptin groups than those in control groups. Linagliptin suppressed LPS‐induced mRNA expression of MCP‐1 and TNF‐α, and inhibited ROS generation in mouse peritoneal macrophages.

**Conclusion**: This study suggests that linagliptin suppresses the progression of atherosclerosis in high‐fat diet‐fed apoE KO mice. Moreover, linagliptin suppresses ROS generation and inflammatory responses in macrophages. These findings may indicate the beneficial effects of linagliptin for the prevention of diabetic macrovascular complications in subjects with T2D.
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FNDC5/irisin contributes to glucose‐stimulating insulin secretion and suppress in high glucose {#jdi12938-sec-0038}
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^1^Department of Internal Medicine, Division of Endocrinology and Metabolism, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C.^2^Department of Internal Medicine, Division of Endocrinology and Metabolism, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan, R.O.C.^3^Department of Internal Medicine, Division of Nephrology, Tri‐Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.^4^School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.^5^Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C.^6^Deputy Superintendent, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan, R.O.C.^7^School of Medicine, College of Medicine, Fu Jen Catholic University, Taiwan, R.O.C.^8^Department of Internal Medicine, Division of Endocrinology and Metabolism, Fu Jen Catholic University Hospital, Taiwan, R.O.C.

**Background**: Irisin, a novel exercise‐stimulating myokine and cleavage of fibronectin type III domain containing 5 (FNDC5). Some evidences showed irisin is associated with regulation of glucose homeostasis. In the present study, we explored the role of irisin on insulin secretion of islet in obesity and type 2 diabetes (T2D).

**Materials and Methods**: C57B6/J and BALB/c mice fed with high‐fat diet (HFD, 40% fat) in obesity group. Mice were fed with high‐fat diet and treated streptozotocin and nicotinamide for T2D group. In *in vitro* study, murine β cells (NIT‐1 cells) were treated with normal glucose (7 mM) or high glucose (25 mM). Culture medium was collected, and irisin levels were measured. Western blot was performed for assessing FNDC5 expression in β cells. Moreover, insulin secretion rate of NIT‐1 cells in normal or high glucose or palmitate stimulation was assessed with after silencing FNDC5 by siRNA.

**Results**: In *in vivo* study, the levels of circulating irisin in mice significantly increased initially, but declination of irisin level followed in T2D group. However, immunohistochemical stain of islet showed FNDC5 expression was similar between control and obesity group, but significantly decreased in T2D group. In *in vitro* study, insulin secretion of β cells significantly decelerated after silence by FNDC5 siRNA in both normal and high glucose. However, insulin secretion of β cells after palmitate challenge was not affected after FNDC5 silence. Moreover, FNDC5 expression of β cells significantly declined in high glucose. Meanwhile, irisin secretion of β cells also declines in high glucose.

**Conclusion**: FNDC5 expression in β cells declined, but circulating irisin levels increased in T2D mice. FNDC5 contributed to glucose‐stimulating insulin secretion in both normal and high glucose. High glucose suppressed FNDC5 expression and irisin excretion in β cells.
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The influence of injury factors on miRNAs profiles of exosomes derived from islets and serum blood {#jdi12938-sec-0040}
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**Q. Fu, H. Jiang and T. Yang**

The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Islets damage is a major abnormality underling diabetes; thus, timely monitoring islets destruction is critically needed. Recent studies discovered the biological functions of exosomes and suggested the value of exosomes in disease diagnosis and prognosis. This study aimed to investigate the impact of injury factors on the miRNA profiles of islet exosomes and determine whether circulating exosomal miRNAs would be suitable as biomarkers of islets cell damage. Islets were isolated from ICR mice and induced injury in vitro by mixed cytokines (TNFα, IL‐1β and IFNγ) and streptozotocin (STZ), and exosomes were derived from the cultural supernatant. Using miRNA microarray analysis, we found 22 and 11 differentially expressed miRNAs in islet exosomes of STZ and cytokines treatment, respectively. Six differentially expressed exosomal miRNAs were found both in STZ and cytokines treated group, and miR‐375‐3p and miR‐129‐5p were validated by qRT‐PCR. Serum exosomes were isolated from ICR mice of islets damage in vivo induced by STZ injection and subjects with various glucose metabolism states and diabetic duration. QRT‐PCR demonstrated exosomal miR‐375‐3p dramatically increased in serum of STZ treated mouse prior to the disturbance of blood glucose and serum insulin. In human serum exosomes, miR‐375‐3p was elevated in new‐onset diabetes patients. Overall, our results suggest that injury factors cytokines and STZ affected the miRNA profiles of exosomes derived from islets and exosomal miR‐375‐3p showed promising potential as a biomarker of islets damage.
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Dipeptidyl peptidase‐4 inhibitor has a much great impact on bioactive glucose‐dependent insulinotropic polypeptide in type 2 diabetes {#jdi12938-sec-0042}
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**T. Yanagimachi^1^, F. Yukihiro^1^, J. Honjo^1,2^, Y. Takeda^1^, H. Sakagami^1^, A. Abiko^1^, T. Ota^1^, H. Yokoyama^2^ and M. Haneda^1^**

^1^Asahikawa Medical University, Asahikawa, Japan^2^Jiyugaoka Medical Clinic, Obihiro, Japan

**Background and Aims**: Some ELISA kits have been developed to measure specifically active incretins and glucagon, but it is unclear if the assays can accurately quantify bioactivities. We determined active glucose‐dependent insulinotropic polypeptide (GIP), glucagon‐like peptide‐1 (GLP‐1) and glucagon levels in type 2 diabetes (T2DM) subjects with or without dipeptidyl peptidase‐4 inhibitor (DPP‐4i) treatment using the receptor‐mediated bioassays.

**Material and methods**: We performed meal tolerance test (MTT) in subjects with normal glycemic tolerance (NGT) (*n* = 9) and with T2DM (without DPP‐4i; *n* = 7. with DPP‐4i; *n* = 9). In the additional consecutive study, we performed second MTT after DPP‐4i treatment in subjects with T2DM patients initially without DPP‐4i (*n* = 4). For the receptor‐mediated bioassays, we used the cell lines stably co‐transfected with human‐form GIP, GLP‐1 or glucagon receptor and a CRE‐luciferase expression construct. To evaluate the efficacy of our bioassays, we measured identical samples via commercial ELISA kits.

**Results**: Firstly, we confirmed the responsiveness and specificity of the bioassay using receptor‐specific ligands. While, GIP ELISA kits could not detect GIP(1‐30)NH2. Interestingly, glucagon was degraded by DPP‐4 enzyme in vitro. Postprandial active GIP (bioassay) levels of T2DM with DPP‐4i were significantly higher than those of NGT and T2DM without DPP‐4i during the MTT. Active GIP (bioassay) levels of T2DM with DPP‐4i were increased approximately 15‐fold at 30 min compared to those of T2DM without DPP‐4i. In contrast, total and active GIP (ELISA) levels of T2DM with DPP‐4i at 30 min were just twofold and 2.5‐fold greater than that of T2DM without DPP‐4i, respectively. Though DPP‐4i treatment raised total (ELISA) and active GLP‐1 (bioassay) levels, total and active GLP‐1 levels of T2DM with DPP‐4i at 30 min were only 2.8‐fold and 5.7‐fold greater than that of T2DM without DPP‐4i, respectively. Thus, not active GLP‐1 (bioassay) but active GIP (bioassay) levels were vigorously increased via the administration of DPP‐4i. In the consecutive study, administration of DPP‐4i increased active GIP (bioassay) levels, but neither total (ELISA) nor active GLP‐1 (bioassay). In addition, DPP‐4i significantly reduced incremental AUC0--120 min of glucagon (bioassay).

**Conclusions**: DPP‐4i treatment has a much greater impact on plasma levels of receptor‐mediated bioactive GIP than GLP‐1 in T2DM.
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DPP‐4 inhibitor Teneligliptin attenuates high glucose‐induced beta cell dysfunction via a cAMP‐Sirt1 pathway {#jdi12938-sec-0044}
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**Purpose**: Teneligliptin a newer DPP‐4 inhibitor provides a narrative clinical efficacy and oral tolerability with a unique chemical structure amongst currently available DPP‐4 inhibitors. Recent studies reported that DPP‐4 is expressed in human pancreatic beta cells, and there is no study about the effect of Teneligliptin in the pancreatic beta cells. Herein, we investigated the direct effect of Teneligliptin, on beta‐cell function and survival in response to high glucose conditions.

**Materials and methods**: We subjected INS‐cells and human 1.1b4 pancreatic beta cells to high glucose (30 mM) for 48 hours in the absence or presence of DPP‐4 inhibitor Teneligliptin. Insulin secretion was assessed by Millipore ELISA Kit. Apoptosis was determined by TUNEL In‐Situ cell death detection kit. The protein expression level of GLP1R, Sirt1, JNK and cleaved caspase‐3 signaling and SERCA2B ubiquitination in response to high glucose was assessed by western blot analysis.

**Results**: Exposure of INS‐1 cells or human 1.1b4 pancreatic beta cells to high glucose (30 mM) downregulated GLP1R expression and induces beta‐cell apoptosis. Interestingly, Teneligliptin treatment stabilized GLP1R protein and increased the intracellular cAMP production (*P* \< 0.005) and potentiate glucose‐stimulated insulin secretion (GSIS) (*P* \< 0.05). In parallel, Teneligliptin treatment correlated with the up‐regulation of Sirt1 expression. Further, Teneligliptin treatment significantly decreased the high glucose‐induced reactive oxygen species (ROS) production (*P* \< 0.05) and reduces the JNK mediated p66Shc serine 36 phosphorylation and its mitochondrial translocation and cleaved caspase‐3 activation. Moreover, Teneligliptin counteracted the high glucose‐induced ubiquitination of SERCA2b and lowers the ER stress markers. Interestingly, cAMP pathway inhibition by H89 (PKA inhibitor) blocked the teneligliptin protective effects against the high glucose‐induced beta‐cell apoptosis.

**Conclusion**: Teneligliptin stabilizes GLP1R protein and increasing the cAMP dependent antioxidant response (Sirt1 activation), and its downstream signaling leads to β‐cell function (GSIS) and survival under high glucose conditions. Teneligliptin ameliorates high glucose‐induced endoplasmic reticulum stress by reducing the ubiquitination of SERCA2b. Collectively, our results unveil a direct effect of Teneligliptin on beta‐cell function and survival.
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Glucose‐dependent insulinotropic polypeptide (GIP) hypersecretion is involved in age‐related fat accumulation under normal diet condition in mice {#jdi12938-sec-0046}
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**Background and Purposes**: Fat accumulation with aging is a serious problem; glucose‐dependent insulinotropic polypeptide (GIP) is an incretin that plays an important role in fat accumulation. GIP receptor‐knockout mice show reduced fat mass and improved insulin sensitivity associated with aging. Therefore, GIP is involved in fat accumulation and insulin resistance with aging. However, age‐related changes of GIP secretion remain unclear. The present study aimed to elucidate age‐related changes of GIP secretion and K cells under normal diet condition using GIP reporter mice. In addition, the effects of inhibition of GIP secretion on fat accumulation with aging under normal diet condition were investigated using GIP‐knockout mice.

**Methods**: Male GIP reporter mice were divided into two groups: 3--4 months old (young) mice and 1 year old (aged) mice. Their body composition, GIP secretion, and insulin tolerance were evaluated. Immunohistochemical and flow cytometry analyses were performed to assess K cell number. The expression levels of GIP mRNA and transcriptional factors in sorted K cells were measured. Body weight of male GIP‐knockout mice and their wild‐type littermates was measured over 1 year, and their body composition was evaluated at the age of 1 year.

**Results**: Body weight of aged mice was higher than that of young mice. Aged mice accumulated more body fat, and blood glucose reduction was significantly less in aged mice during insulin tolerance test, indicating that aged mice exhibit the phenotype of fat accumulation and insulin resistance. Aged mice showed hypersecretion of GIP and insulin during oral glucose tolerance test and under free feeding. K cell number was increased in small intestine of aged mice. In aged mice, the mRNA expression levels of GIP and transcriptional factor pancreatic and duodenal homeobox‐1 (Pdx1) were increased in sorted K cells. Body weight of aged GIP‐knockout mice was lower compared with their wild‐type littermates, and aged GIP‐knockout mice accumulated less body fat under normal diet condition.

**Conclusion**: GIP hypersecretion is involved in age‐related fat accumulation under normal diet condition, and the inhibition of GIP secretion prevents fat accumulation with aging.
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Effect of exenatide or lixisenatide on delayed gastric emptying in Japanese patients with type 2 diabetes {#jdi12938-sec-0048}
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**Background and aims**: We previously investigated the effect of liraglutide, a Glucagon‐like peptide‐1 (GLP‐1) receptor agonist (GLP‐1 RA), on gastric emptying. We found that liraglutide treatment either delayed gastric emptying (delayers) or did not delay it (non‐delayers), and the ratio of delayers to non‐delayers was 1:1. However, the maximum dosage of liraglutide approved in Japan (0.9 mg daily) is half of that used in western countries. Accordingly, this study was performed to evaluate the delay of gastric emptying in patients using exenatide (Ex) or lixisenatide (Lix), for which the maximum dosages are the same in Japan and western countries.

**Materials and methods**: An open‐label, non‐randomized, single‐arm study was performed to assess the effect of Ex or Lix on gastric emptying. Thirty patients with type 2 DM who had been admitted for education were enrolled in the study. Ex or Lix therapy was initiated at the usual starting dose, and the dosage was increased to reach the maintenance dose level. The \[13C\]‐acetate breath test was performed to compare gastric emptying before and after initiation of each treatment.

**Results**: There were 15 patients in the Ex group and 15 patients in the Lix group. At baseline, the age was 59 ± 13 years (mean ± SD), BMI was 33.3 ± 9.7, duration of diabetes was 5.3 ± 6.3 years, and HbA1c was 9.3 ± 2.2 % in the Ex group, while the age was 54 ± 12 years, BMI was 31.1 ± 8.9, duration of diabetes was 9.0 ± 8.1 years, and HbA1c was 9.7 ± 2.4 % in the Lix group. In the Ex group, there was an increase of the gastric emptying time based on the maximum \[13C\] acetate concentration (Tmax) compared with that at baseline (from 62 min \[95% CI: 53--72 min\] to 95 min \[95% CI: 46--144 min\], *P* = 0.002). Similarly, there was an increase of Tmax in the Lix group. GLP‐1 RA treatment decreased the plasma glucose AUC from 0 to 4 hour in both groups. There was no difference of the C‐peptide AUC between baseline and after treatment in both groups.

**Conclusion**: All patients were delayers in this study. Ex and Lix both reduced postprandial blood glucose levels without increasing the plasma C‐peptide level.
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Fasting plasma glucose indicates reversibility of acute insulin response after short‐term intensive insulin therapy in patients with type 2 diabetes of various duration {#jdi12938-sec-0050}
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**Objective**: Short‐term intensive insulin therapy (SIIT) reverses β cell dysfunction measured by acute insulin response (AIR) in patients with early type 2 diabetes mellitus (T2DM). However, the complicated procedures limit large‐scale use of AIR. Also, unclear is whether SIIT has positive effects on patients with longer duration. This study is performed to assess fasting indicators estimating recovery of AIR after SIIT for T2DM of various duration.

**Methods**: Patients with T2DM (*n* = 62) who had poor glycemic control were enrolled. Near‐nomoglycaemia was achieved and maintained for 7 days with insulin pump. AIR was measured by intravenous tolerance tests before and after the therapy.

**Results**: Both fasting plasma glucose (FPG, 12.0 ± 3.0 vs. 7.71 ± 1.6 mmol/L, *P* \< 0.001) and 2 h‐postprandial glucose (17.3 ± 5.2 vs. 11.5 ± 3.7 mmol/L, *P* \< 0.001) decreased significantly after SIIT. AIR was improved from −16.7 (−117.4, 52.4) pmol/L·min to 178.7 (31.8, 390.7) pmol/L·min (*P* \< 0.001). Increase of AIR (▵AIR) was observed in all disease duration categories (329.2 ± 380.6, 312.8 ± 347.8, and 123.8 ± 186.3 pmol/L·min for patients with disease duration of \<2 years, 2--6 years, and \>6 years, respectively, *P* = 0.10). AIR was almost absent when FPG was over 10 mmol/L. However, when FPG after SIIT was \<10 mmol/L it was negatively associated with AIR (R = −0.53, *P* \< 0.001) and ▵AIR (R = −0.52, *P* \< 0.001). In multivariate analysis, AIR after the therapy and ▵AIR could be estimated as follows: Estimated AIR (pmol/L·min) = 447.6 × baseline fasting C peptide (nmol/L) -- 138.0× FPG after SIIT (mmol/L) + 925.2 (R^2^ 0.42). Estimated ▵AIR (pmol/L·min) = 401.4 × baseline fasting C peptide (nmol/L) -- 136.8 × FPG after SIIT (mmol/L) −357.6 × HDL‐C after SIIT (mmol/L) + 1380.0 (R^2^ 0.50).

**Conclusions**: Recovery of AIR could be obtained in patients with various duration of T2DM, and it could be estimated conveniently by FPG and other fasting indicators.
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**Background and aims**: Glucagon‐like peptide‐1 receptor agonists (GLP1‐RAs) are classified into short‐ and long‐acting agents depending on their pharmacokinetic differences. It is suggested that they exert different actions on insulin and glucagon secretions as well as on gastric emptying. However, alterations in insulin and glucagon secretions and gastric emptying and their contributions to glycaemia in short‐ and long‐acting agents have not been fully evaluated.

**Materials and methods**: We performed meal tolerance test before and 12 weeks after initiation of the long‐acting GLP‐1RA dulaglutide (Dula), liraglutide (Lira) or the short‐acting GLP‐1RA lixisenatide (Lixi) in Japanese patients with type 2 diabetes. Plasma glucose, insulin, and glucagon were measured using blood sampling, and gastric emptying was measured using ^13^C breath test for 4 hours after solid test meal (280 kcal carbohydrate, 100 kcal protein, 100 kcal fat and ^13^C‐sodium acetate 200 mg). Gastric emptying rate (T1/2) was analyzed based on the time‐plot of pulmonary ^13^CO2 excretion rate (% dose/h) according to the Wagner‐Nelson method. Data (mean ± SEM) were evaluated using ANOVA, student\'s t‐tests or paired t‐test. *P* \< 0.05 was considered significant.

**Results**: Before initiation of the GLP‐1RA agents, there were no significant differences in HbA1c, BMI or duration between the groups (Dula, *n* = 5; age (year) 51.8 ± 3.4; duration (year) 4.6 ± 1.0; Lira, *n* = 6; age 49.0 ± 4.7; duration 8.2 ± 3.8; Lixi, *n* = 7; age45.6 ± 0.9; duration 4.6 ± 1.9). After 12 wks administration of maximum dose agents (Dula 0.75 mg/ Lira 0.9 mg/ Lixi 20ug in Japan), HbA1c was significantly improved in all groups, whereas bodyweight was improved only in Lira and Lixi groups (HbA1c (%): Dula, 8.6 ± 0.4 to 6.6 ± 0.2; Lira, 9.0 ± 0.3 to 6.6 ± 0.4; Lixi, 8.2 ± 0.6 to 6.3 ± 0.1/BMI (kg/m^2^): Dula, 27.0 ± 1.8 to 26.6 ± 1.7; Lira, 28.9 ± 1.2 to 26.8 ± 1.0; Lixi, 32.8 ± 2.3 to 31.2 ± 2.2). Gastric emptying was delayed in Lixi but not in Dula or Lira group (T1/2 (min): Dula, 26.3 ± 1.7 to 31.1 ± 4.3 min; Lira, 33.5 ± 6.3 to 29.1 ± 3.8 min; Lixi, 26.4 ± 2.5 to 64.4 ± 13.0). Postprandial insulin secretion was significantly enhanced in Dula and Lira but not in Lixi group. Postprandial glucagon secretion was decreased but not significantly changed in all groups.

**Conclusion**: These results suggest that long‐acting agents improve glycemic control through enhanced insulin secretion and that short‐acting agents do so through delayed gastric emptying.
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Dietary pattern with high energy and leucine‐rich protein is associated with the skeletal muscle index in Japanese patients with type 2 diabetes {#jdi12938-sec-0054}
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**S. Moyama^1,3^, Y. Hamamoto^2,3^, H. Kuwata^1,2,3^, T. Kurose^2^, D. Yabe^2^ and Y. Seino^2,3^**

^1^Kansai Electric Power Hospital -- Center for Metabolism and Clinical Nutrition, Osaka, Japan^2^Kansai Electric Power Medical Research Institute ‐Center for Diabetes Research, Osaka, Japan^3^Kansai Electric Power Hospital -- Center for Diabetes, Endocrinology and Metabolism, Osaka, Japan

**Background and aims**: The maintenance of the skeletal muscle mass is important to the prevention of sarcopenia. Although several studies reported the relationship between individual foods and nutrients, and body composition, whether dietary patterns identified by principal component analysis are also associated with the body composition, especially with skeletal muscle mass, is not known. Dietary patterns may better capture the multifaceted effects of diet on body composition than individual nutrients or foods. The aim of this study was to examine the relationship between dietary patterns and skeletal muscle index (SMI) in Japanese patients with type 2 diabetes.

**Materials and methods**: From 2015 to 2018, we carried out a cross‐sectional study in 153 type 2 diabetes patients (93 males and 60 females, mean age 66.4 ± 9.4 years) without a history of dietary interventions. In all subjects, 3‐day dietary surveys and body composition measurements were conducted using the self‐administered dietary record and the bioelectricity impedance measuring device (InBody S10). Dietary patterns were generated using principal component analysis of the consumption of 18 food items, and correlational analyses were performed between SMI and identified dietary patterns.

**Results**: A total of 18 patterns were identified. Among them, two dietary patterns explained 23.8% of the total variance of food intake, and the rest was low contributed. Dietary pattern 1, 'oils and meats‐rich pattern', characterized by high intakes of oils and fats, grains, and meats and eggs, was significantly correlated with SMI (r = 0.271, *P* \< 0.001). In the results of multiple regression analysis, leucine was independently associated with the dietary pattern among essential amino acids (t = 2.78, *P* \< 0.01). However, dietary pattern 2, "egg and vegetable‐rich pattern", characterized by high intakes of eggs, nuts and seeds, vegetables, and potato, was not associated with SMI.

**Conclusion**: Our data suggest that dietary pattern, characterized by high intakes of energy and leucine‐rich protein, relates to the prevention of sarcopenia in Japanese patients with type 2 diabetes.
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**L. Zhang^1^, H. Li^1^, L. Qian^1^, L. Shen^2^ and W. Jia^1^**

^1^Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, China^2^Department of Clinical Nutrition, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital Shanghai, 200233, China, Shanghai, China

**Objective**: Resistant starch (RS) has been reported to reduce body fat in obese mice. However, this effect has not been demonstrated in human. In this study, we tested the effects of RS in 19 volunteers with normal body weight.

**Methods**: A randomized, double‐blinded and crossover designed clinical trial was conducted. The study subjects were given either 40 g HAM‐RS2 or energy‐matched control starch, along affording with three identical diets per day throughout the study. GLP‐1 and PYY were detected by enzyme‐linked immunosorbent assay (ELISA), and visceral fat area (VFA) and subcutaneous fat area (SFA) were measured by magnetic resonance imaging. Blood and urine metabolomics were detected by liquid chromatography. SCFAs were detected by gas chromatography. 16s RNA pyrosequencing was used to study gut microbiota.

**Results**: VFA showed a significant reduction after 4‐week RS intake compared to that after CS consumption (27.05 ± 2.67 vs. 21.70 ± 1.78 cm², *P* \< 0.001) in normal‐weight subjects. The reduction was also observed in SFA (134.65 ± 10.18 vs. 127.33 ± 10.66 cm², *P* \< 0.001). At 30 min after meal, a significant increase in the levels of insulin (56.98 ± 7.57 vs. 69.70 ± 6.90 μU/ml, *P* \< 0.05), C‐peptide (5.72 ± 0.48 vs. 6.59 ± 0.45 ng/ml, *P* \< 0.01), and GLP‐1 \[2.53 (1.83,3.89) vs. 2.78 (2.26,3.09) pM, *P* \< 0.01\] was seen after RS intake compared to that after CS consumption. Meanwhile, the serum SCFA acetate was significantly increased after RS intake compared to that after CS consumption \[53.34 (41.58,63.18) vs.38.79 (30.81,44.38) nM, *P* \< 0.001\], and the change of acetate after starch consumption was positively correlated with the postprandial change of GLP‐1 at 30 min (r = 0.460, *P* = 0.006). Furthermore, certain gut microbiota significantly decreased after RS supplementation, whereas *Ruminococcaceae_UCG‐005* genus showed an increase in abundance. Other potential signatures of RS intervention included *Akkermansia*,*Ruminococcus_2*,*Victivallis*, and *Comamonas*. Moreover, the baseline abundance of genera *Streptococcus*,*Ruminococcus_torques_group*,*Eubacterium_hallii_group*, and *Eubacterium_eligens_group* were significantly associated with the hormonal and metabolic effects of RS.

**Conclusion**: These observations suggest that a daily intake of 40 g of RS is effective in modulating body fat, SCFA and early‐phase insulin and GLP‐1 secretions and gut microbiota in normal‐weight subjects.

OP‐28 {#jdi12938-sec-0057}
=====

Interventional effect of resistant starch diet on nonalcoholic fatty liver disease, a randomized clinical trial {#jdi12938-sec-0058}
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**L. Qian, H. Li, L. Zhang, Q. Fang, L. Wu, J. Zhang and W. Jia**

Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, China

**Aim**: Resistant starch (RS), a kind of prebiotics, can be fermented in the colon by microbiota and has beneficial effects on inflammatory bowel disease, colon tumor and so on. In animal studies, RS can reduce serum triglyceride, total cholesterol and body fat. In human studies, RS intervention by 2--12 weeks can reduce total cholesterol in metabolic syndrome patients. We performed a randomized and blinded clinical trial to investigate the effect of RS on hepatic lipid metabolism and inflammatory damages in patients with non‐alcoholic fatty liver disease (NAFLD).

**Methods**: In this clinical trial (ChiCTR‐IOR‐15007519), 200 NAFLD participants were randomized and given RS (40 grams/day) or control corn starch (CS, equicaloric) for 16 weeks. They received dietary advice from the dietitian and were asked not to change their exercise habits. Intrahepatic triglyceride content (IHTG) was measured by proton magnetic resonance spectroscopy. Glucose metabolism, insulin sensitivity, lipid and liver enzyme profiles were evaluated by meal tolerance tests. Visceral adipose tissue areas (VFA) and subcutaneous adipose tissue areas (SFA) were assessed by abdominal MRI. Serum cytokeratin 18 (CK18) M65ED and fibroblast growth factor 21 (FGF21) were detected by enzyme‐linked immunosorbent assay.

**Results**: IHTG was significantly reduced in RS group compared with CS group at 16 weeks (10.52 (5.52, 17.73) % versus 19.2 (8.17, 28.34)%, *P* \< 0.01). Bodyweight, waist circumference, and blood pressure were significantly reduced in RS group. Fasting serum insulin and HOMA‐IR index decreased significantly in RS group. A total of 17% subjects got NAFLD remission after RS intervention. Serum CK18 M65ED was reduced by 50%, and FGF21 levels were reduced by 28.6% in RS group compared with CS group. In the subgroup analysis among suspected nonalcoholic steatohepatitis (NASH) individuals (alanine transaminase, ALT ≥ 40 U/L), IHTG was also reduced in RS group (15.32 (8.95, 22.36) % versus 24.71 (15.08, 36.76) %, *P* \< 0.01). ALT can also decrease significantly. ALT of 73.5% subjects became normal. Serum CK18 M65ED and FGF21 levels in this subgroup also decreased.

**Conclusions**: RS diet intervention can reduce the IHTG in NAFLD, alleviate suspected NASH and may provide a new approach for clinical intervention of NAFLD.
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**R. T. R. Nadia^1^ and M. N. Nurain^2^**

^1^Hospital Sultanah Nurzahirah, Kuala Terengganu, Malaysia^2^Hospital Putrajaya, Putrajaya, Malaysia

**Background**: Patient with Diabetes and Chronic Kidney Disease (CKD) is exempted from fasting. Previous studies revealed increased risk of hypoglycaemia, hyperglycaemia and variable renal function during fasting.

**Objective**: To evaluate Glycaemic Excursions (GE) and Variability (GV) in Type 2 Diabetes Mellitus (T2DM) with CKD during non‐fasting and Ramadan fasting period using Continuous Glucose Monitoring Systems (CGMS). The secondary objective was to compare demographic data (renal function (MDRD eGFR), weight and total daily insulin dosages (TDD)) during non‐fasting and Ramadan fasting period.

**Methodology**: An observational, cross‐sectional study involving CKD stage II‐III patients withT2DM, who fasted during Ramadan 2016 (1437Hijri). The study was conducted at Endocrine Unit, Hospital Putrajaya Malaysia. Patients were put on 72 hours CGMS monitoring 2 weeks prior to Ramadan (non‐fasting) and during 3rd--4th weeks of Ramadan. GE and GV were retrieved from CGMS recording, and parameters were evaluated and compared.

**Results**: There were 12 T2DM patients, median age of 60.5 years, with mean HbA1c of 7.7%. A total of 10 patients were in CKD stage III, and most of the patients were on intensive insulin therapy (83.3%). Hypoglycaemia (glucose \<3.9 mmol/L) was noted in 4 patients during non‐fasting period (33.3%). Hypoglycaemic episodes were mild‐moderate in severity, asymptomatic and mostly nocturnal. During Ramadan, 5 patients (41.7%) had asymptomatic hypoglycaemia, mostly in the evening and pre‐iftar. During non‐fasting period,11 patients had hyperglycaemia (glucose more than 10 mmol/L), predominantly post‐meal. The same patients had hyperglycaemic episodes during Ramadan mainly post‐iftar and overnight (12am until 3am). GV parameters suggested intraday (quantified by high SD, MAGE, CONGA‐1), inter‐day variability (quantified by MODD) with high hyperglycemic risk (high HBGI) during non‐fasting period with similar pattern noted during Ramadan Fasting. There was significant reduction of MDRD eGFR (mean of 49.0 to 42.0 mls/min/1.73 m^2^), weight (77.4 to 75.4 kg) and TDD of basal bolus insulin (median of 77.6 to 59.2 IU/day) in subjects during Ramadan fasting.

**Conclusion**: During Ramadan fasting, T2DM patients with mainly CKD Stage III had episodes of hypoglycaemia, hyperglycaemia and increased intra and inter‐day variability. However the same pattern of GV was seen in a non‐fasting state. There was significant reduction of renal function, weight and TDD of basal bolus insulin in subjects during Ramadan.
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**J. Moon^1^, J. Park^1^, S. You^1,2^, H. Chin^3^ and G. Koh^1,2^**

^1^Department of Internal Medicine, Jeju National University Hospital, Republic of Korea, Jeju‐city, South Korea^2^Department of Internal Medicine, Jeju National University School of Medicine, Jeju‐city, South Lorea^3^Department of Internal Medicine, Jeju Medical Center, Jeju‐city, South Lorea

**Background and aims**: Monnier et al. showed greater contributions of postprandial (PHG) and fasting(FHG) hyperglycemiae to overall hyperglycaemia at lower and higher HbA1c, respectively. However, it has never been studied in Korean diabetic patients. In addition, there have been few studies about determinant factors in postprandial and fasting glucose levels. Therefore, we assessed the relative contributions of PHG and FHG to the overall hyperglycemia and the influencing factors on PHG and FHG in Korean patients with type 2 diabetes.

**Material and methods**: We enrolled 195 Korean type 2 diabetic patients which did not take insulin or α‐glucosidase inhibitor. They performed a seven‐point self‐monitoring of blood glucose (7‐point SMBG) more than once during each month for 3 consecutive months. Glucose area under the curve (AUC) above 100 mg/dL (5.5 mmol/L) was defined as AUC (total) to represent the overall hyperglycemia. The area under the curve above fasting glucose level was considered the postprandial hyperglycemia (AUC(PHG)). The fasting hyperglycemia (AUC(FHG)) was calculated as \[(AUC(total) -- AUC(PHG)\]. The relative contributions of PHG and FHG to overall hyperglycaemia were, respectively, defined as the proportions of AUC(PHG) and AUC(FHG) to AUC(TOTAL).

**Results**: The relative contribution of PHG showed a significant difference and gradual decrement according to increasing quartiles of HbA1c (66.9 ± 6.0, 36.1 ± 6.0, 40.3 ± 3.2, 32.3 ± 3.8%; P(ANOVA) \< 0.001, P(TREND) \< 0.001). And the contribution of FHG was increased progressively with increasing quartiles of HbA1c (33.0 ± 9.5, 63.8 ± 6.0, 59.6 ± 3.2, 67.6 ± 3.8%; P(ANOVA) \< 0.001, P(TREND) \< 0.001). AUC(PHG) was positively correlated to age (r = 0.191; *P* \< 0.01), systolic blood pressure (r = 0.185; *P* \< 0.01), duration of diabetes age (r = 0.185; *P* \< 0.01), C‐peptide (r = 0.198; *P* \< 0.01), HbA1c (r = 0.282; *P* \< 0.01), and hsCRP (r = 0.145; *P* \< 0.05). AUC(FHG) was positively correlated to body weight (r = 0.190; *P* \< 0.01), waist circumference (r = 0.185; *P* \< 0.01), C‐peptide (r = 0.217; *P* \< 0.01), HbA1c (r = 0.658; *P* \< 0.01), alanine aminotransferase (r = 0.228; *P* \< 0.01), and triglyceride (r = 0.278; *P* \< 0.01) but negatively correlated to age (r = −0.146; *P* \< 0.05). Using multiple linear regression to adjust for age, sex and other covariates, only age (β = 0.181; *P* \< 0.05) and triglyceride (β = 0.150; *P* \< 0.01) remained significant variables of the AUC(PHG) and AUC(FHG), respectively.

**Conclusions**: In Korean type 2 diabetic patients, postprandial hyperglycemia predominantly contributes to overall hyperglycemia at lower HbA1c level, whereas fasting hyperglycemia is a predominant contributor to it at higher HbA1c level. And age and plasma triglyceride are independent predictors of postprandial and fasting hyperglycemiae, respectively.
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Sedentary time and its association with glycemic control in Thai patients with type 2 diabetes {#jdi12938-sec-0064}
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**J. Haruethai, T. Yotsapon, H. Kritchana, N. Chadaporn, K. Sasiwapach, C. Panita, K. Sallaya and H. Thep**

Diabetes and Thyroid Center, Theptarin Hospital, Bangkok, Thailand

**Background and Objectives**: Maintenance active lifestyle is crucial for blood glucose and overall health in people with type 2 diabetes (T2DM). Previous studies showed that higher amounts of sedentary time are associated with increased mortality and morbidity, poorer glycemic control and influence on cardiometabolic health. Given the limited data of physical activity (PA) in Thai T2DM, this study aimed to characterize patterns of PA, sedentary behavior and their associations with dietary intakes and glycemic control.

**Materials and Methods**: A cross‐sectional study of outpatients with T2DM in Theptarin hospital was done by using 72‐hour food record. Trained dietitians conducted the interview for assessing PA by using WHO\'s Global Physical Activity Questionnaire. All PA components, which including work‐related movement, transportation‐related locomotion, exercise, and sedentary behavior, were calculated based on their intensity, duration and frequency of action to obtain the mean physical activity level (PAL). The association between PAL, dietary intakes and glycemic control was evaluated.

**Results**: A total of 213 diabetes patients (females 49%, mean age 58.4 ± 10.5 years, BMI 26.8 ± 4.6 kg/m^2^, duration of diabetes 12 ± 9 years, baseline HbA1c 7.1 ± 1.2%, insulin treatment 19%) participated in the study. The mean calorie intake was 1494 ± 439 kcal/day, and mean intake for each macronutrient was accepted (Carbohydrate 51%, Protein 17%, Fat 32%). Almost 60% of the patients were inactive and only 13% of patients achieved recommended level for PAL. For person who had PAL ≥ 600 MET/wk are younger (54.1 ± 10.7 vs. 59.1 ± 10.4, *P* = 0.023), higher energy intake (1695 ± 533 vs. 1465 ± 417, *P* = 0.039) mostly from dietary fat (62 ± 23 vs. 52 ± 20, *P* = 0.016) while they have a slightly better diet quality (AHEI 29 ± 7 vs. 25 ± 9, *P* = 0.039).

**Conclusions**: More than a half of Thai T2DM were physical inactive and lower diet quality. Targeted behavior change strategies should be used to increase physical activity in adults with T2DM. Increasing unstructured physical activity should be encouraged as part of a whole‐day approach, or at least initially as a first step for individuals who are sedentary and unable/reluctant to participate in more structured exercise.
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**Purpose**: Diabetes is a widespread chronic disease, and the total diabetes population is estimated at around 2.2 million out of the 23 million residents in Taiwan. This abstract describes the design and current status of the Taiwan Diabetes Registry (TDR).

**Methods**: The Diabetes Association of the Republic of China (Taiwan) launched the Taiwan Diabetes Registry (TDR) in Oct. 2015. The enrolled subjects comprised three patient groups, including those ever participating in two waves of diabetes quality survey in 2006 and 2011 (group 1), type 1 diabetes (group 2), and type 2 diabetes diagnosed within one year (group 3). The general characteristics, reports of blood and urine tests, diabetic complications evaluation, and use of medications were recorded at baseline and then every 1--2 years. In addition, patients' health status and health‐related quality of life were obtained by questionnaire interview.

**Results**: A total of 13 medical centers, 19 regional and local hospitals and 32 general practice clinics participated in the TDR. Until May 31, 2018, a total of 5,417 patients with diabetes, including 1,218 in group 1 (mean ± SD, 66.5 ± 12.6 years; M/F 645/573), 1,088 type 1 diabetes in group 2 (33.9 ± 14.0 years; M/F 435/653), and 3,111 newly diagnosed type 2 diabetes in group 3 (55.1 ± 13.9 years; M/F 1759/1352) were enrolled. Among them, 462 and 181 patients (37.9% and 14.9%) in group 1, 529 and 111 (48.6% and 10.2%) in group 2, and 633 and 88 (20.4% and 2.8%) in group 3 completed the year 1 and year 2 annual follow‐up tests, respectively.

**Conclusions**: The data of the TDR are continuously expanding, and we anticipate that it will become a valuable source to address relevant information in diabetes profiles and management.
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Association of SCARBI and PON1 gene polymorphisms with type 2 diabetes mellitus in Northern Indian Population {#jdi12938-sec-0068}
-------------------------------------------------------------------------------------------------------------

**M. Wamique and W. Ali**

King George\'s Medical University, Lucknow, India

**Introduction**: Diabetes mellitus is a complex metabolic disorder in which pancreatic beta cells become dysfunctional and cause insulin resistance or decreased production of insulin. PON1 is HDL associated enzyme and secreted primarily in the liver also known to inhibit LDL oxidative modification and prevents the accumulation of oxidized LDL by elevating cholesterol efflux. Scavenger receptor class B member 1 (SCARB1) gene located on chromosome 12q24 consisting of 509 amino acid protein with molecular weight 82KDa has linked to diabetes in many studies. Which acts as HDL receptor involved in reverse cholesterol transport expresses in liver.

**Aim**: Single‐nucleotide polymorphism in Paraoxonase 1 is associated with Q‐R at 192 positions and C‐T at position 1020 of the SCARB1 gene that has been associated with variability in enzyme levels. Therefore, based on this we tried to investigate the association of PON1 (Q192R) and SCARB1(C1020T) polymorphisms with the risk of developing T2DM in Northern Indian Population and to evaluate the relationship of these polymorphisms with PON1 levels.

**Methods**: In the present case‐control study, 300 type 2 Diabetes mellitus patients and 300 healthy volunteer were recruited. The genotypes of PON1 and SCARB1 were determined by RFLP‐PCR; human serum PON1 level was measured by ELISA kit, and biochemical analysis was done using standard protocol.

**Results**: The frequencies of CC and RR, QR were significantly higher in T2DM patients compared with healthy controls. Furthermore, the C and R alleles were significantly associated with type 2 diabetes with an Odds Ratio of 1.41 and 1.48, respectively. RR and QR genotypes were significantly associated with higher LDL and low HDL. Moreover, SCARB1 CC genotype was associated with higher LDL and CT genotype with low HDL, PON1 levels in type 2 diabetes mellitus.

**Conclusion**: RR and CC genotype is significantly associated with type 2 diabetes mellitus. PON1 and SCARB1 gene can be a good candidate for T2DM susceptibility among Northern Indians.
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FADS1‐FADS2 genetic polymorphisms are associated with fatty acid metabolism through changes in DNA methylation and gene expression {#jdi12938-sec-0070}
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**Z. He**

Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, China

**Purpose**: Genome‐wide association studies (GWASs) have shown that genetic variants are important determinants of free fatty acid levels. The mechanisms underlying the associations between genetic variants and free fatty acid levels are incompletely understood. Here, we aimed to identify genetic markers that could influence diverse fatty acid levels in a Chinese population and uncover the molecular mechanisms in terms of DNA methylation and gene expression.

**Methods**: Using datasets of Infinium Exome BeadChip and serum FFAs profile, we screened the genome for common variants associated with serum forty‐two fatty acids in 297 individuals. EpiTYPER™ assay and qPCR were, respectively, applied for measurement of DNA methylation level and gene expression in visceral fatty tissue from 42 individuals.

**Results**: We identified strong associations between single‐nucleotide polymorphisms (SNPs) in the fatty acid desaturase (*FADS*) region and multiple polyunsaturated fatty acids. Expression quantitative trait loci (eQTL) analysis of rs174570 on *FADS1* and *FADS2* mRNA levels proved that minor allele of rs174570 was associated with decreased *FADS1* and *FADS2* expression levels (*P* \< 0.05). Methylation quantitative trait loci (mQTL) analysis of rs174570 on DNA methylation levels in three selected regions of *FADS* region showed that the methylation levels at four CpG sites in *FADS1*, one CpG sites in intragenic region, and three CpG sites in *FADS2* were strongly associated with rs174570 (*P* \< 0.05). Then, we demonstrated that methylation levels at three CpG sites in *FADS1* were negatively associated with *FADS1* and *FADS2* expression, while two CpG sites in *FADS2* were positively associated with *FADS1* and *FADS2* expression. Using mediation analysis, we further show that the observed effect of rs174570 on gene expression was tightly correlated with the effect predicted through association with methylation.

**Conclusions**: Our findings suggest that genetic variants in the *FADS* region are major genetic modifiers that can regulate fatty acid metabolism through epigenetic gene regulation.
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**N. K. Loganadan^1^, H. Z. Huri^1^, S. R. Vethakkan^1^ and Z. Hussein^2^**
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The ABCC8 and KCNJ11 genes encode the SUR‐1 and Kir6.2 receptors of the KATP channel of the pancreatic beta cell, respectively, where sulphonylureas bind and stimulate insulin release. Several polymorphisms of these genes have been associated with poor response to sulphonylureas. The aim of this study was to identify the genetic predictors of secondary sulphonylurea failure in Malaysian Type 2 Diabetes (T2D) patients. In this prospective multicentre study (SUCLINGEN) conducted from September 2014 until April 2017 at seven out‐patient clinics across Malaysia, T2D patients aged 18 years and above who had been receiving maximum doses of sulphonylurea and metformin for ≥1 year were recruited. Those who received other concurrent antidiabetic agents or insulin, not adherent to medications, had history of pancreatic surgery or renal impairment (eGFR \< 30 ml/min) were excluded. Secondary sulphonylurea failure defined as HbA1c \> 7.0 % (53 mmol/mol) was assessed after a 12‐months follow‐up. The blood samples of subjects were taken at baseline from which their DNA samples were extracted using the QIAamp^®^ DNA Blood Mini Kit (QIAGEN, Germany). Genotyping for rs757110 (ABCC8 gene), rs5219 (KCNJ11 gene), rs7756992 (CDKAL1 gene) and rs2237892 (KCNQ1 gene) polymorphisms was done using the DNA samples and Taqman genotyping assays (Applied Biosystems, USA). A total of 401 subjects were included in the final analysis, and the incidence of secondary sulphonylurea failure after 12 months was 65.3%. The risk allele homozygotes (CC) for the rs757110 (ABCC8 gene) polymorphism had significantly higher incidence of sulphonylurea failure (18.3%) than no failure (10.8%) (*P* = 0.049). The odds for secondary sulphonylurea failure was 1.4 times higher \[OR = 1.407 (1.037--1.907), *P* = 0.034\] in those harbouring the risk allele T for the rs5219 (KCNJ11 gene) polymorphism compared to those carrying the C allele. The associations of rs7756992 and rs2237892 polymorphisms with secondary sulphonylurea failure were not statistically significant (*P *\> 0.05). In conclusion, this study have shown that carrying the risk allele for both the rs757110 and rs5219 polymorphisms was associated with significantly increased risk for secondary sulphonylurea failure in Malaysian T2D patients, suggesting a possible role of sulphonylurea pharmacogenomics in T2D management in Malaysia.
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Peking University People\'s Hospital, Beijing, China

**Background**: The prevalence of diabetic kidney disease (DKD) had rose with the increasing incidence of diabetes globally, and DKD is the major cause of end‐stage renal disease (ESRD). Several evidences suggested that genetic factor might be the important factor in the development of DKD. Genetic study on DKD is helpful for understanding the pathogenesis of DKD and finding out the possible therapeutic targets and very vital for improving prognosis in patients with T2DM. Our study aimed to identify novel candidate genes associated with DKD by whole‐exome sequencing.

**Subjects and Methods**: A total of 165 youth‐onset diabetes patients were collected from 2014 to 2015, including 73 patients with DKD and 92 patients without DKD, to perform whole‐exome sequencing. We screened the variants which only occurred in DKD group but not non‐DKD group with duration more than 5 years (*n* = 38), then we screened the whole exons of candidate genes by target regions sequencing in the next collected patients with youth‐onset diabetes from 2015 to 2017 (*n* = 376) aimed to find out more patients with rare variants in candidate genes and analyzed the characteristics of these patients.

**Results**: We found that the rare variants in exons and splice sites of PPARG, TBC1D4 and RASGRP1 genes might be associated with DKD. Four rare variants in PPARG gene, six rare variants in TBC1D4 and three rare variants in RASGRP1 had been identified via next‐generation sequencing. Patients with PPARG variants both had severe insulin tolerance and hypertriglyceridemia. Patients with TBC1D4 variants most were obesity. Patients with RASGRP1 variants had a common clinical feature related to obviously impaired beta‐cell function and immune dysfunction.

**Conclusion**: By whole‐exome sequencing method, we found the rare variants in PPARG, TBC1D4 and RASGRP1 genes might be associated with DKD in Chinese patients with youth‐onset diabetes. The patients carrying mutations in PPARG, TBC1D4 and RASGRP1 genes had their own clinical features associated with these gene dysfunctions. On the basis of identification of causal genes, we might find new intervention target and lay the foundation for T2DM and DKD treatments.
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Coronary heart disease (CHD) is the leading cause of death among patients with type 2 diabetes (T2D). Previous studies demonstrated that genetic factors play a role in CHD, with more than 100 genetic loci being identified in genome‐wide association studies (GWAS) for CHD by far. However, the genetic basis for CHD in patients with T2D remains unclear. This study aimed to uncover genetic variants that affected CHD in Chinese patients with T2D. We also examined the associations of 97 SNPs in 69 reported gene regions identified from previous GWAS with CHD. We performed a meta‐analysis of GWAS using data generated from the Hong Kong Diabetes Register (HKDR) study and the Hong Kong Diabetes Biobank (HKDB). CHD was defined as acute myocardial infarction or death due to coronary disease, or other nonfatal CHD (including revascularisation). We have examined a total of 2374 cases in T2D patients with CHD, and 6246 controls with duration of T2D more than 10 years and free from cardiovascular diseases including CHD, stroke and peripheral vascular disease. DNA samples were genotyped using the Illumina HumanOmni2.5Exome‐8 BeadChip and the Illumina Infinium^®^ Global Screening Array (GSA) in HKDR and HKDB studies, respectively. We imputed the genotypes using minimac 3, with 1000 Genome Project phase III data as reference panel. Within gender, ˜6.6 million high‐quality common SNPs (MAF ≥1%) were examined using logistic regression model, with the adjustments for age and principal components. Results of sex‐specific association in the two studies were combined by meta‐analysis. A total of 233 SNPs were associated with CHD at threshold of *P* \< 10^−5^ from 10 distinct genomic regions, including two previously reported loci (*WDR12* and *CDKN2A/B*) and eight novel loci on chromosomes 1, 2, 12, 14, 15, 20 and 22. Among 69 reported loci from published studies, we confirmed the associations of 9 loci with CHD (2.0×10^−4^ \< *P* \< 0.0322), but none of them reached genome‐wide significance. We have identified eight novel suggestive loci associated with CHD in Chinese patients with T2D. Our findings also support the important contribution of the reported loci for CHD in T2D patients compared with general population.
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**Background and aims**: The IDMPS is the largest ever observational study program that describes patient profiles, management, and patterns of care across time of people with type 1 (T1D) and type 2 (T2D) diabetes in developing regions. We investigated changes in management and in cardiovascular risk factors over time in participants with T2D observed between 2005 and 2017 in 48 countries across Africa, the Middle East, South Asia, Latin America, Asia, and Eurasia.

**Materials and methods**: Data including blood pressure (BP), lipids, and concomitant medication were collected in 7 individual waves, each enrolling different participants.

**Results**: Representative data from Waves 1 and 7 are shown here (all‐wave data to follow). General use of cardioprotective drugs rose in both insulin and non‐insulin‐treated people; use of renin‐angiotensin system inhibitors (ARBs) rose from 24.3--24.7% to 43.6--46.1% of participants between Waves 1 and 7, while use of angiotensin conversion enzyme inhibitors (ACEI) fell from 54.4--58.8% to 40.1--40.3% of participants. Fewer people had micro/macrovascular complications in Wave 7 versus Wave 1 (from 70.9% to 42.1% in non‐insulin‐treated people, and from 86.1% to 65.3% in insulin‐treated people), and fewer participants reported angina (reduced from 22.4% to 5.1% in non‐insulin‐treated people, and from 23.8% to 9.9% in insulin‐treated people). Among insulin‐treated people, there was a general rise in HbA1c, BP, and lipid levels despite increasing treatment rate. Using HbA1c \< 7 %, BP \<130/80 mmHg, and LDL‐C \<2.6 mmol/l (ABC goals) as intermediate surrogates for future cardiovascular events, the proportion of people who attained 2/3 targets increased from 22.2% to 26.5% in non‐insulin‐treated people and were constant in insulin‐treated people (16.9% and 16.5%) in Waves 1 and 7, respectively.

**Conclusion**: Despite the diversity of clinical settings in developing countries, these data suggest that better awareness/care provision may have influenced the increased treatment rate and control of risk factors in T2D. However, the burden of cardiovascular disease remains high (especially in insulin‐treated people). Early diagnosis and intensified intervention may reduce exposure to these risk factors and future risk of cardiovascular disease.
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**Background and aims**: New therapies and technologies mean that diabetes treatment has evolved over the last decade. We investigated whether the evolution of diabetes treatment over time has had any impact on the degree of glycemic control and the frequency of diabetes‐related complications in people with type 2 diabetes (T2D) in the developing world over this period.

**Materials and methods**: The IDMPS is the largest ever observational study program that describes patient profiles, management, and patterns of care across time of people with type 1 diabetes (T1D) and T2D in developing regions. From 2005 to 2017, data were collected in 7 individual waves. Each wave enrolled different participants from 48 countries across Africa, the Middle East, South Asia, Latin America, Asia, and Eurasia. Achievement of target HbA1c, number of hospitalizations, and number/type of diabetes‐related complications were recorded, as were details of oral/injectable therapies received.

**Results**: Mean disease duration ranged across waves from 6.8--7.6 years (participants receiving OGLDs only) and 12.1--13.3 years (participants receiving insulin ± OGLDs, or OGLDs + insulin). From Wave 1 to Wave 7, no improvement in the proportion of individuals achieving HbA1c \<7 % was seen. The proportions of participants with micro‐ and macrovascular complications decreased in both treatment groups over time (from 70.9 to 42.1% in participants on OGLDs alone, and from 86.1 to 65.3% in participants on insulin ± OGLDs, or OGLDs + insulin). The proportion of participants receiving OGLDs + insulin rose over time from 16.4 to 30.7%. The median daily dose of insulin was 0.26--0.53 IU/kg in 2005 and 0.35--057 IU/kg in 2017; median BMI at diagnosis increased from 27.1--27.3 kg/m^2^ in Wave 1 to 30.2--30.4 kg/m^2^ in Wave 7.

**Conclusion**: Despite the introduction of new drugs/technologies, there has only been a small improvement in the degree of metabolic control or experience of chronic complications for people with T2D in the developing world. For optimum outcomes, provision of new therapeutic tools should be accompanied by education of people with diabetes and their medical teams on proper use.
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**Objective**: To analyse the microbiologic profile and antibiotic sensitivity patterns of diabetic foot infections (DFIs) during last 20 years in China, and the difference in different regions and climates.

**Methods**: We searched CNKI, CBM, VIP, WAN FANG, PubMed, Embase and Medline of comprehensive literature on DFIs in China from January 1996 to December 2014. Classified the included studies in subtropical or warm temperate zone based on climate types. Divided the last 20 years into two periods, 1996--2009 and 2009--2014. Data extracted from the literature to analysis.

**Results**: A total of 6755 pathogenic bacteria strains were isolated from 6124 DF patients among 42 studies, in which Gram‐positive(G+) bacteria was 47.3%, Gram‐negative(G‐) bacteria was 45.9% and fungus was 5.9%. The top five bacteria were *Staphylococcus aureus, E. coli, Enterococcus, Proteus and Pseudomonas aeruginosa*. Compared 1996--2009 and 2009--2014, the G+ bacteria decreased from 49.8% to 45.8% (*P* = 0.003), G‐ bacteria increased from 43.8% to 46.6% (*P* = 0.036) and fungus rised from 5.5% to 6.3% (*P* = 0.186). Meanwhile, cultivating positive rate ascended from 76.9% to 87.4%( *P* \< 0.001). In subtropical region, the degree of Light and Heavy group was 27.45% and 66.25%, while in warm temperate region it was 13.86% and 86.14%, respectively. The percentage of G+ and G‐ bacteria accounted for 48.14% and 43.77% in subtropical region, whereas it was 44.75% and 51.73% in warm temperate region. While Imipenem, Meropenem and Piperacillin‐tazobactam were the most active against Gram‐negative microorganisms, linezolid and vancomycin were the most active agents against Gram‐positive microorganisms.

**Conclusions**: Gram‐positive pathogens decreased while gram‐negative pathogens increased in recent 5 years. Meanwhile, fungus, polymicrobia infection and multiple drug resistance presented a rised trend. Compared with warm regions, there were high proportion of heavy DF and more G‐ pathogens in subtropic areas. Drug resistance rate of main bacterial on commonly used antibiotics was also in different. This data may be used for empirical antibiotics, reducing resistance patterns, and minimizing healthcare costs.
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**Background**: Care fragmentation, lack of education and poor self‐management support can lead to suboptimal health outcomes.

**Aim**: To use public‐private‐partnerships (PPP) for establishing technologically enhanced, nurse‐led Diabetes Centres to set up registers, empower patients and promote patient‐provider communication in type 2 diabetes (T2D).

**Methods**: Between 2007 and 2015, 16,530 patients with T2D underwent structured diabetes assessment performed by trained nurses with data entry into the JADE portal. Patients were categorized into four groups according to the care setting when first enrolled into the JADE Register. The public care (PC; *n* = 3491) and JADE‐PC (*n* = 9607) groups underwent assessment with follow‐up by different doctors in public setting. The JADE‐PC group received a JADE report with group explanation by nurses. Both JADE‐PPP‐Public and JADE‐PPP‐Private groups underwent assessment at the university affiliated, self‐funded Diabetes Centre with individualized explanation of the JADE report by nurses and follow‐up by different doctors in public sector (*n* = 2153) or same private doctor (*n* = 1279). The primary outcome was any incident cardiovascular‐renal diseases, all‐site cancer and all‐cause death expressed as cases per 1000‐person‐years with 95% confidence interval (CI), with data censored on 30 June 2017.

**Results**: At enrolment, 90% of the cohort (mean ± SD age = 60.3 ± 11.6 years, median diabetes duration = 7.0 years \[IQR 2.0--14.0\]) had multiple risk factors or complications. A total of 2686 primary events were accrued during 51208 person‐years of follow‐up. Compared to the PC group (66.22 \[CI 61.20--71.54\]), the JADE‐PPP‐Private group (28.05 \[24.11--32.46; *P* \< 0.001\]) had the lowest incidence of primary outcome, followed by the JADE‐PPP‐Public (38.49 \[34.70--42.57; *P* \< 0.001\]) and JADE‐PC groups (57.97, \[55.15--60.89; *P* = 0.005\]). Compared to the PC group, the adjusted hazard ratios (aHR) for primary outcome were 0.39 (0.31--0.50; JADE‐PPP‐Private), 0.55 (0.45--0.67; JADE‐PPP‐Public) and 0.72 (0.62--0.83; JADE‐PC). The JADE‐PPP‐Private (aHR 0.33, CI 0.26--0.41), JADE‐PPP‐Public (aHR 0.47, CI 0.39--0.56) and JADE‐PC (aHR 0.63, CI 0.55--0.72) groups also had lower risk of chronic kidney disease while the JADE‐PPP‐Private (aHR 0.31, CI 0.13--0.77) and JADE‐PC (aHR 0.54, CI 0.35--0.84) had lower risk of heart failure, compared to the PC group.

**Conclusion**: A technologically enhanced Diabetes Centre supported by PPP improves clinical outcomes by establishing registers, empowering patients, improving patient‐provider communication and facilitating continuing medical care.
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Omentin, also known as intelectin‐1, is an adipokine predominantly expressed in visceral adipose tissue and has insulin‐sensitizing and vasculoprotective effects, like adiponectin, in rodents. Previous studies indicated the associations of plasma omentin levels with carotid atherosclerosis, arterial stiffness, endothelial function, or coronary artery disease mainly in the non‐diabetic population. In this study, we investigated the association between plasma omentin levels and carotid atherosclerosis in patients with type 2 diabetes. We included 416 patients with type 2 diabetes in this study. Fasting plasma omentin levels and total adiponectin levels were measured by ELISA, and the mean intima‐media thickness (IMT) of the common carotid artery was measured by ultrasonography. The medians of plasma omentin level, adiponectin level, and IMT were 572 ng/mL, 6.1 μg/mL, and 0.76 mm, respectively. Eighty‐seven (21%) subjects had the history of cardiovascular diseases (CVD), including coronary artery disease, cerebrovascular disease, or peripheral artery disease, which was based on medical records. Plasma omentin levels were positively correlated with age, systolic blood pressure, serum creatinine, and adiponectin, and negatively correlated with BMI, IRI, HOMA‐R, triglycerides, in a similar manner to plasma adiponectin levels. Plasma omentin levels were higher, and the mean IMT was greater in the subgroup with CVD than that without CVD. Multivariate analysis in the total population showed that plasma omentin levels were not significantly associated with IMT after adjustment for adiponectin levels and traditional CVD risk factors. However, subgroup analysis revealed that plasma omentin level was an independent determinant of IMT (*β* = −0.134, *P* = 0.023) in the subgroup without CVD, but not in that with CVD. In conclusion, plasma omentin levels are associated with atherosclerosis, independently of adiponectin levels and traditional CVD risk factors, in type 2 diabetes patients without CVD. This study indicates a protective role of omentin against atherosclerosis in type 2 diabetes patients without CVD, but not in those with CVD.
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**Purpose**: We present a non‐invasive approach, remote sensing hyperspectral imaging, as a novel tool for detecting diabetic peripheral neuropathy.

**Method**: Patients with type 2 diabetes regularly visited the outpatient departments for at least 1 year were enrolled. Hyperspectral imaging of bilateral feet was evaluated, measuring the mean squared error (MSE) as an index; most researches in the field of hyperspectral image compression provide results using the MES index as well as application‐specific metrics and employ classification as benchmark application. We also arranged several examinations, including Michigan Neuropathy Screening Instrument (MNSI) examinations and 10gm monofilament test, electrochemical skin conductance (ESC) measured by Sudoscan, 6‐item questionnaire (ID‐Pain), and ankle--brachial index with brachial‐ankle pulse wave velocity (ba‐PWV). Patients with a history of arrhythmia, stroke, amputations, estimated glomerular filtration rate (eGFR) \<15 mL·min^−1^·per 1.73 m^2^, those undergoing dialysis, diagnosed with a malignancy, had ulcerative wound or amputation of lower limbs were excluded. We collected clinical and demographic data, including: gender; age; body mass index; and biochemical data including fasting plasma glucose, glycosylated hemoglobin (HbA1c), serum creatinine, lipid profiles, and urine albumin‐to‐creatinine ratio (UACR).

**Results**: A total of 15 patients with type 2 diabetes with a mean age of 60.1 ± 11.7 years old (male/female: 8/7) were enrolled. Results of the correlation analysis between MSE index of hyperspectral imaging significant correlated with sum of abnormal points of 10gm monofilament test (which evaluate large fiber peripheral neuropathy), ESCs of feet (an early detectable abnormality in diabetic small fiber neuropathy), systolic blood pressure, ba‐PWV, and eGFR (*P* \< 0.05), with the Pearson correlation coefficients of 0.72, −0.53, 0.56, 0.61, and −0.59, respectively.

**Conclusions**: In this pilot study, we founded that MSE index obtained by hyperspectral imaging significantly highly correlated with large fiber diabetic peripheral neuropathy detected by 10gm monofilament test. Both hyperspectral imaging MSE index and diabetic peripheral neuropathy measured by monofilament test were significantly correlated with renal function presented by eGFR. Remote sensing hyperspectral imaging considered to be a novel non‐invasive remote sensing tool to detect detecting diabetic peripheral neuropathy and maybe related to other chronic complications of diabetes, such as arterial stiffness and diabetic kidney disease.
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Aims Pathogenic factors driving obesity to type 2 diabetes have not been fully elucidated. Group 1 innate lymphoid cells (ILC1s) play roles in obesity‐induced insulin resistance, but whether they contribute to obesity‐related glycemic deterioration in humans remain unclear. This study aimed to assess the role of adipose tissue ILC1s in development of obesity‐related type 2 diabetes.

**Methods**: We enrolled 36 non‐obese controls who underwent abdominal surgery and 39 obese subjects who underwent metabolic surgery. A total of 12 obese subjects were diagnosed as type 2 diabetes. Omental adipose tissue and blood samples were collected to determine the number of ILC1s on a flow‐cytometer. Histological analysis, immunoblot and an in vitro co‐culture system were used to assess the role of ILC1s in obesity‐related adipose stress. Rag1^−/−^ mice were utilized to study the role of adipose ILC1s in obesity‐related metabolic disorders in vivo.

**Results**: Adipose and circulating ILC1s numbers increased significantly in obese subjects and more dramatically in obese type 2 diabetic patients, compared to non‐obese controls. Adipose ILC1s were positively associated with fasting glucose and HbA1c levels. Importantly, adipose ILC1s positively correlated with circulating ILC1s, which decreased markedly in line with improvement of fasting blood glucose and HbA1c levels 3 months post‐surgery. Moreover, adipose ILC1s were positively related with insulin resistance and adipose fibrosis. Subjects with more adipose ILC1s showed decreased AKT phosphorylation, increased fibrosis levels and M1 macrophage numbers in adipose tissue. In vitro co‐culture experiments further showed that adipose stromal vascular fractions from subjects with more adipose ILC1s secreted larger amounts of IFN‐γ and directly up‐regulated expressions of fibrosis related genes, compared to that from subjects with less adipose ILC1s. Inhibiting adipose ILC1s accumulation via anti‐IL‐12 neutralizing antibodies in Rag1^−/−^ mice significantly improved high‐fat diet‐induced glucose intolerance and adipose fibrosis.

**Conclusions**: These data firstly demonstrated that adipose ILC1s plays a vital role in obesity‐related glycemic deterioration. Importantly, adipose tissue fibrosis and systemic insulin resistance induced by adipose ILC1s provides novel insights into the pathogenic mechanism of local immune disturbances in human obesity. Adipose ILC1s may thus serve as a novel therapeutic target in obesity‐related type 2 diabetes.

OP‐45 {#jdi12938-sec-0091}
=====

Association between diabetes mellitus and urinary incontinence in elderly patients {#jdi12938-sec-0092}
----------------------------------------------------------------------------------

**H. V. T. Thanh^1^, H. N. T. Thu^1,2^, T. N. Xuan^2^, T. N. Ngoc^1,2^, T. N. T. Hoai^2^, H. D. T. Hong^3^, V. D. Thanh^4^, T. Pham^1,2^ and H. V. T. Thanh^1,2^**

^1^Department of Gerontology, Hanoi Medical University, Hanoi, Vietnam^2^National Geriatric Hospital, Hanoi, Vietnam^3^Dong Anh General Hospital, Hanoi, Vietnam^4^Hung Yen General Hospital, Hung Yen, Vietnam

**Background and Aim**: Urinary incontinence (UI) has been known as a problem associated with diabetes, especially in elderly. The aging process and geriatric syndromes contribute to the incidence of UI. The aim of the study was to assess characteristics of UI and related factors in elderly diabetic patients.

**Materials and methods**: We conducted a cross‐sectional study on 322 diabetic patients aged ≥60 years, who were admitted to the National Geriatric Hospital from December 2016 to December 2017. The 3 incontinence questions (3IQ) were used to identify the prevalence of UI and the types of incontinence. Information on socio‐demography, medical history, glycaemic control (fasting plasma glucose -- FPG) and HbA1c), comorbidities (Charlson index), polypharmacy, cognitive impairment was assessed to investigate the relationship of diabetes mellitus and UI.

**Results**: Three hundred twenty‐two patients were recruited. Age of subjects was ranging between 60 and 96 years old (average age: 74.8 ± 8.28 years). The prevalence of UI among patients with diabetes was 65.2%. The prevalence of urgent, stress, overflow and mixed incontinence was 36.7%, 36.2%, 17.6% and 9.5%, respectively. Advanced age, long duration of diabetes, using insulin therapy, high HbA1c (≥7%); history of stroke and pelvic surgery were associated with UI (*P* \< 0.05). The prevalence of UI was significantly higher in the diabetic patients having cognitive impairment and polypharmacy than those in the non‐geriatric syndromes group (*P* \< 0.05). Multiple logistic regressions revealed risk factors for UI including History of pelvic surgery (OR:4.7, 95% CI: 1.3--16.3, *P* \< 0.05); Long duration of diabetes (OR: 2.7, 95% CI: 1.2--6.0, *P* \< 0.05); Charlson index (OR: 2.2, 95% CI: 1.3--3.6, *P* \< 0.05); Polypharmacy (OR: 4.2, 95% CI: 2.0--9.0, *P* \< 0.001) and Cognitive impairment (OR: 26.3, 95% CI: 3.2--218.7, *P* \< 0.05).

**Conclusion**: Diabetes mellitus was associated with urinary incontinence in elderly patients. Especially, history of stroke and pelvic surgery, long duration of diabetes, comorbidities, polypharmacy and cognitive impairment were associated with the risk of UI.
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Effect of switching from pioglitazone to the SGLT2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus {#jdi12938-sec-0094}
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**Background and aims**: In several large‐scale trials, SGLT2 inhibitors suppressed cardiovascular events in patients with type 2 diabetes. Thiazolidine had similar and other positive pleiotropic effects. However, the difference in the effects on glycemic control or other metabolism‐related factors has not been elucidated between the hypoglycemic agents. We performed a randomized controlled trial to compare the effects of dapagliflozin and pioglitazone on glycemic control and body weight in patients with type 2 diabetes.

**Materials and methods**: In this open‐label, prospective, randomized, parallel‐group comparison trial, 71 patients with type 2 diabetes who took pioglitazone either switched to dapagliflozin at 5 mg per day (*n* = 36) or continued pioglitazone (*n* = 35). The primary outcome was the superiority of weight loss and noninferiority of HbA1c with the dapagliflozin group at week 24.

**Results**: In the dapagliflozin group, the patients' body weight decreased by \>4.5 kg compared with that in the pioglitazone group (dapagliflozin, 75.3 ± 14.9 kg to 71.3 ± 15.1 kg; pioglitazone, 74.7 ± 13.8 kg to 75.2 ± 13.9 kg; *P* \< 0.01). The change in HbA1c was similar (dapagliflozin, 6.9 ± 0.5% to 7.0 ± 0.7%; pioglitazone, 6.9 ± 0.6% to 7.1 ± 0.8%), although the insulin and C‐peptide levels were elevated only in the pioglitazone group at week 24 (insulin, *P* = 0.02; C‐peptide, *P* = 0.02). The primary outcomes (change in body weight and HbA1c) had no relationship with each other in the dapagliflozin group but showed a significant positive correlation in the pioglitazone group (r = 0.455, *P* = 0.006). They had no relationship with any other parameters. The N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) level and urinary albumin‐creatinine ratio (ACR) significantly decreased only in the dapagliflozin group (NT‐proBNP, *P* \< 0.01; ACR, *P* = 0.02), and the change in NT‐proBNP was negatively correlated with the baseline NT‐proBNP (r = −0.91, *P* \< 0.01) and ACR (r = −0.65, *P* \< 0.01). There were no differences in blood pressure, liver function, or lipid levels between baseline and 24 weeks or between the two groups. There were no serious adverse events in either group.

**Conclusion**: Compared with pioglitazone, dapagliflozin exerts more beneficial effects on body weight loss, which may preserve endogenous insulin secretion and optimize the excess body fluid volume, potentially reducing the occurrence of cardiovascular events.
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**Background and aims**: Evogliptin is a new dipeptidyl peptidase‐4 (DPP‐4) inhibitor. We investigated the efficacy and safety of dipeptidyl peptidase‐4 (DPP‐4) inhibitor evogliptin vs linagliptin in drug‐naïve patients with type 2 diabetes, using continuous glucose monitoring system (CGMS).

**Materials and methods**: A total of 207 patients with type 2 diabetes (mean age 56 ± 10.3 years; body mass index 26.1 ± 3.4 kg/m^2^) who had HbA1c 7.0--10.0% were randomized 1:1 for 5 mg evogliptin (*N* = 102) or 5 mg linagliptin (*N* = 105) once daily for 12 weeks. The primary efficacy endpoint was the change from baseline glycated hemoglobin (HbA1c) at week 12 in a full analysis set. Non‐inferiority margin was defined when the upper limit of the two‐sided 95% confidence interval (CI) of the HbA1c difference between the treatments was \<0.40%. CGM parameters were measured at baseline and week 12 to evaluate the glycaemic variability and hypoglycemia in both groups.

**Results**: The mean changes in HbA1c of evogliptin 5 mg group and linagliptin 5 mg group were −0.85% and −0.75%, respectively. The between‐group difference was −0.10% (two‐sided 95% CI, −0.32 to 0.11%), demonstrating non‐inferiority. Fasting plasma glucose concentrations significantly decreased from 144.1 mg/dl to 131.3 mg/dl in evogliptin and from 151.1 mg/dl to 135.7 mg/dl in linagliptin without significant difference between two groups. In glycemic target goal, 44.0% in evogliptin group and 36.5% in linagliptin achieved HbA1c \<6.5% at week 12. In general, both medications were well tolerated, and incidence and types of adverse events were comparable between the two groups. After 12 weeks, the changes in mean amplitude of glycaemic excursion (MAGE) were −24.6 mg/dL in the evogliptin group and −16.7 mg/dL in the linagliptin group, which were significantly lower compared with baseline values in both groups. The standard deviation (SD) of glucose and postprandial glycemic excursion decreased significantly in both groups at week 12. Hypoglycemic events, mostly mild, were reported in 1.98% of patients with evogliptin and 4.76% of patients with linagliptin for 12 weeks.

**Conclusion**: In this multicenter, randomized, active‐control study, once‐daily evogliptin 5 mg treatment significantly decreased HbA1c levels by 0.85% and improved glycemic variability without any significant adverse events in drug‐naïve Korean patients with type 2 diabetes.
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**Purpose**: Type 2 diabetes (T2D) is a known risk factor for sarcopenia. The liver plays a central role in glucose metabolism; recently, a few studies reported that liver fibrosis was associated with a decrease in skeletal muscle mass. Therefore, the relation between liver fibrosis and physical function needs to be elucidated. We investigated the association between liver fibrosis index, muscle quality and physical function in male patients with T2D.

**Method**: We performed a cross‐sectional study in male inpatients with T2D recruited from February 2015 to November 2016. FIB‐4 index was calculated as a surrogate marker of liver fibrosis. Skeletal muscle mass and body fat mass were estimated by bioelectrical impedance analysis measurements. Muscle thickness (MT) and echo intensity (EI) of the vastus lateralis muscle were measured by B‐mode ultrasonography. EI was determined by gray scale and corrected for subcutaneous fat thickness. Knee extensor strength (KES), one leg standing time with eyes open (OLST), maximum walking speed (MWS) and 6‐minute walk distance (6MWD) were measured to assess physical function. KES was divided by body weight. The relationships between variables were examined by Pearson\'s correlation analyses. Multiple regression analysis was performed to investigate the contributing independent variables. Statistical significance was defined as *P* \< 0.05.

**Result**: We examined 218 male patients with T2D who were given exercise instruction (age: 63.1 ± 11.8 years, BMI: 25.9 ± 4.1 kg/m^2^, HbA1c: 9.4 ± 1.9 %, diabetic duration: 12.8 ± 11.0 years). The mean FIB‐4 index was 1.71 ± 1.11, and 26 of the patients (11.9%) were supposed to have liver fibrosis by the cut‐off value of FIB‐4 index \>2.67. FIB‐4 index was positively associated with age, diabetic duration, BMI, body fat percentage and EI, and negatively associated with KES, OLST and 6MWD. On the other hand, FIB‐4 index was not associated with appendicular skeletal muscle mass index and MT. Multiple regression analysis demonstrated that FIB‐4 index was independently associated with EI after adjusting for age. Furthermore, EI was negatively associated with KES, OLST and 6MWD.

**Conclusion**: FIB‐4 index is associated with decreased muscle quality and physical function in male patients with T2D.
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**Background and aims**: Recent proteomic analysis using Long‐Evans Agouti rats, a spontaneous model of type 2 diabetes (DM), in a prediabetic state reveals that serum α1 antichymotrypsin (α1ACT) is a biomarker of DM progression. However, pathophysiological roles of α1ACT in glucose intolerance in human remain unknown. In this study, we aimed to investigate the association between α1ACT and glucose metabolism in individuals with varying degrees of glucose tolerance.

**Materials and methods**: The 75‐g oral glucose tolerance test was carried out in 75 Japanese individuals not taking diabetes medications \[age: 65 ± 11 (mean ± SD); male/female: 34/41; BMI: 24.9 ± 3.8\]. Participants were classified into NGT, IGT and DM groups (each group: *n* = 25). The insulinogenic index (IGI) as an index of insulin secretion, and QUICKI and the Matsuda Index (MI) as indices of insulin sensitivity were calculated. Fasting serum levels of α1ACT were assayed by ELISA. Normally distributed loge‐transformed (ln‐) values were used for regression analysis in some cases.

**Results**: In simple regression analysis in each group, α1ACT was not correlated with BMI, IGI and glucose levels during OGTT in all 3 groups. Interestingly, α1ACT was correlated with QUICKI (r = 0.557) and ln‐MI (r = 0.498) only in IGT, although BMI was correlated with QUICKI and ln‐MI in all 3 groups. In multiple regression analysis, QUICKI was independently predicted by BMI (β = −0.451) and α1ACT (β = 0.474), accounting for 50.6 % (*P* = 0.0004) of the variability of the dependent variable, which was larger than that in the prediction by BMI alone (28.9 %). Ln‐MI was also independently predicted by BMI (β = −0.368) and α1ACT (β = 0.426), accounting for 39.3 % (*P* = 0.0041) of the variability of the dependent variable.

**Conclusion**: It was found that α1ACT, a prediabetic biomarker in rats, was correlated with insulin sensitivity independently of BMI in Japanese individuals with IGT.
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**Introduction**: In Japan, obesity has tended to decrease among women, especially those of childbearing age, over the past ten years. We focused on inadequate muscle mass as a cause of gestational diabetes mellitus (GDM) in non‐obese pregnant women without impaired insulin secretion. This study investigated the association of muscle mass with insulin resistance, as evaluated by the insulin sensitivity index (ISI), in Japanese patients with GDM.

**Materials and Methods**: A prospective observational study was performed by enrolling consecutive GDM patients admitted to St. Marianna University Hospital (Kawasaki, Japan) between October 2015 and March 2018. A total of 96 Japanese women with GDM were admitted for initial education and glycemic control; none of them were hospitalized for urgent metabolic or perinatal complications. To evaluate insulin resistance, we calculated the ISI according to the following formula: ISI = 10,000/square root of \[fasting glucose × fasting insulin\]  ×  \[mean glucose × mean insulin during the OGTT\]). Body composition was measured by performing bioelectrical impedance analysis after urination and before lunch.

**Results**: The subjects were aged 34.4 ± 4.4 years (mean ± SD), and BMI before pregnancy was 22.5 ± 4.4 kg/m^2^. Fifty‐three patients (55.2%) had a history of diabetes in first‐degree relatives. At admission, fasting plasma glucose was 86.4 ± 8.5 mg/dL and HbA1c was 5.3 ± 0.3%. ISI (calculated from OGTT data) was 7.2 ± 3.3. Appendicular muscle mass (AMM) was 17.0 ± 2.1 kg, and fat mass (FM) was 18.8 ± 8.2 kg. The AMM/FM ratio was 1.0 ± 0.4. A positive correlation was noted between FM and AMM (r = 0.586, *P* \< 0.001). To adjust for confounders when evaluating the association of AMM with ISI, multivariate analysis was conducted using age, family history of diabetes, and FM. The AMM/FM ratio showed a significant positive correlation with ISI (▫ = 0.37, *P* = 0.014).

**Conclusions**: These findings suggest that reduced muscle mass is an important factor for development of insulin resistance in Japanese patients with GDM. Too much emphasis on beauty rather than health might result in inadequate muscle mass for normal glucose metabolism.
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**Objective**: Beta cells in different stages have different function and capacity of proliferation, regenerative and apoptosis. We conducted this study to investigate whether there are changes in beta‐cell phonotype in the development of diabetes to identify potential beta cell targets for preventing the progression of diabetes.

**Methods**: We conducted a cross‐sectional study of pancreatic tissues obtained from 80 patients classified into three groups: 25 type 2 diabetes, 25 impaired fasting glucose, and 30 non‐diabetes. We utilize the ratio of insulin‐positive area/pancreas area as an indirect mark for beta‐cell mass. Insulin‐positive duct cells and scattered beta cells were defined as neogenesis beta cells. Insulin/Ngn3, Insulin/Mafa and Insulin/P16 double‐positive cells were defined as immature, mature and senescent beta cells, respectively. Ki67 marked cell proliferation, and tunel marked cell apoptosis. The ratio of insulin‐positive area/pancreas area, as well as the prevalence of insulin‐positive duct cells, scattered beta cells and Insulin/Ngn3, Insulin/Mafa, Insulin/P16, Insulin/Ki67 and Insulin/Tunel double‐positive cells was calculated. The main statistical method, we used was the Kruskal‐Wallis test.

**Results**: There is no significant difference in beta‐cell mass, the prevalence of insulin‐positive duct cells, scattered beta cells and Insulin/Ngn3, Insulin/Mafa and Insulin/Ki67 double‐positive cells among the groups. The incidence of Insulin/P16 double‐positive cells (6.25 (3.83, 8.91) vs 3.88 (2.73, 6.75) vs 3.20 (2.54, 5.68) %, *P* = 0.041) increased in type2 diabetes compared with non‐diabetes (*P* = 0.039). Beta‐cell apoptosis (0.27 (0.12, 1.38) vs 0.41 (0.11, 0.69) vs 0.07 (0.00, 0.45)%, *P* = 0.003) was significantly increased in type2 diabetes (*P* = 0.007) and impaired fasting glucose (*P* = 0.020).

**Conclusions**: Beta‐cells' senescence and apoptosis may be involved in the course of diabetes.
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**Aims**: Although immunoglobulin G Fc receptors with an immunoreceptor tyrosine‐based activation motif (ITAM‐FcγRs) have been implicated in mediating inflammatory responses, the importance in the pathogenesis of cognitive impairment in geriatric diabetes remains unclear. The present study investigated the potential role of ITAM‐FcγRs on cognitive impairment in geriatric diabetes.

**Methods**: Diabetes was induced by streptozotocin in aged Wistar rats for assessment of cognitive function and cerebral injury at 8 weeks using Morris water maze, real‐time PCR and western blot analysis. In vitro, the inhibition of ITAM‐FcγRs was investigated using rat chromaffin cell cultured with high glucose.

**Results**: Aged rats with diabetes exhibited marked and persistent learning and memory impairments. Enhanced cerebral inflammation in diabetic aged rats was associated with over‐activation of the nuclear factor κB (NF‐κB) signaling pathway and upregulation of inflammatory cytokines (IL‐6, TNF‐α) in the hippocampus. Compared with the diabetic group, knockdown of FcγRIV (main isoform of the ITAM‐FcγRs) markedly attenuated cognitive impairment as well as the histologic and ultrastructural pathologic change. Increased inflammatory cytokines and over‐activation of NF‐κB signaling pathway were also significantly alleviated. In vitro, high glucose significantly activated NF‐κB signaling pathway and increased inflammatory cytokines. Inhibition with FcγRIV small interfering RNA and/or FcγRI and FcγRIII neutralizing antibody significantly ameliorated the effects mediated by high glucose.

**Conclusion**: Enhanced activation of NF‐κB signalling pathways may be the mechanisms by which ITAM‐FcγRs promote cerebral inflammation and cognitive impairment under diabetic conditions. ITAM‐FcγRs may be viewed as a potentia21 l target for preventative intervention of cognitive impairment in older adults with diabetes.
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Obesity involves cytokine‐mediated chronic inflammation. Interleukin‐13 (IL‐13) is an anti‐inflammatory cytokine that is mainly secreted by T‐helper cells 2 cells and also adipose tissue macrophages. Transgene administration of *IL13* gene in mice showed anti‐obesity effects have a common coding gene variant in *IL13* at codon 130 (rs20541 or R130Q) results in enhanced effector mechanisms in allergic inflammation and also has been extensively associated with allergies and chronic inflammatory diseases in ethnically diverse populations. However, its role in obesity is still unknown. Therefore, the objective of this study was to investigate the association of *IL13* R130Q with obesity‐related traits among 440 Malaysian University students (M/F: 207/233; Chinese/Indians: 416/24). Anthropometric measurements were taken, and genotyping was performed by Taqman^®^ assay using DNA extracted from mouthwash samples. The effect of R130Q on adipogenesis of differentiated mouse adipocytes 3T3‐L1 was also investigated by transient transfection (TT) or recombinant protein treatment (RP) of human wild‐type (R130) or mutant (Q130) IL‐13. Adipogenesis was assessed by Oil Red O staining, expression of adipogenesis genes and phospho‐acetyl‐CoA carboxylase (pACC) protein expression. Lipolysis activity was quantified by free glycerol concentration, and levels of pro‐inflammatory cytokine IL‐1β were measured by ELISA. R130Q genotypes were significantly associated with waist circumference and total body fat (TBF) classes (both *P* = 0.02). Logistic regression analysis further revealed that QQ genotype subjects had increased risk of having high TBF (OR = 2.60; 95% CI = 1.27, 5.32; *P* = 0.01 and OR = 2.35; 95% CI = 1.14, 4.85; *P* = 0.02 when unadjusted or adjusted for ethnicity, respectively). Q130 either by TT or RP significantly increased adipogenesis compared to R130, by elevating lipid droplet accumulation, increasing gene expression of *C/EBPα, PPARγ2* and aP2, and decreasing pACC protein expression. Lower concentration of free glycerol released from adipocytes subjected to Q130 TT or RP signifies lower lipolysis activity, compared to R130. There was also decreased secretion of IL‐1β in adipocytes exposed to R130, while this effect was diminished in Q130 exposure. Taken together, Q130 IL‐13 is associated with human adiposity and increases adipogenesis *in vitro*, either by transgene overexpression or recombinant protein treatment. This suggests that this coding gene variant may have functional effects in the pathogenesis of obesity.
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**Objective**: We aim to explore the role of LXR activation in modulating autophagic activity in podocytes and diabetic kidney.

**Methods**: We established mouse podocyte cell line to investigate the effect of LXR agonists on podocytes autophagic activity and related signaling pathway by performing Western blotting, real‐time RT‐PCR, GFP‐mRFP‐LC3 transfection and immunofluorescence staining. Then, the C57BL/6J mice were randomized into three groups: nondiabetic control mice (NC), STZ‐induced diabetic mice (DM), and diabetic mice treated with the LXR agonist TO901317 (DM + TO901317). Diabetes was induced by peritoneal injection of STZ. Pathological staining, transmission electron microscopy and immunohistochemistry were applied to explore the effect of TO901317 on diabetic kidney.

**Results**: In this study, we found that LXRs activation could inhibit the expression of LC3B‐II and Beclin1 and increase the expression of p62 (*P* \< 0.01) which was achieved by blocking the formation of autophagosome in podocytes. Moreover, the expression of LC3B‐II increased in the absence of LXRβ. LXR agonists could attenuate the expression level of podocyte marker proteins significantly (*P* \< 0.01) and could impair AMPK activation, reduce the expression level of SIRT1, and increase the phosphorylation of mTOR simultaneously (*P* \< 0.01). Combining LXR agonists with mTOR inhibitor could slightly increase the expression of LC3B‐II, podocin and nephrin. In diabetic mice model, despite the fact that LXRs activation could ameliorate glomerular hypertrophy, mesangial matrix expansion and interstitial fibrosis, the albuminuria was not improved (*P* \> 0.05). Moreover, the administration of LXRs agonist caused autophagy suppression in glomeruli and decreased podocytes marker protein expression in diabetic mice (*P* \< 0.01), leading to aggravated podocytes loss and foot processes alterations.

**Conclusion**: In summary, our findings indicate that activation of LXRs induced autophagy suppression, which in turn contributed to the podocytes injury both *in vitro* and *in vivo*. This study provides a warning rationale for further investigations of LXR activation in diabetic kidney, and continued investigation of the combination therapy with mTOR inhibitor as well as AMPK or SIRT1 agonist is particularly warranted.
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**Objective**: To investigate the effects of circ_0001982 on protecting the metabolic syndrome (MetS), and discuss the molecular mechanism of circ_0001982 ameliorates the insulin resistance (IR) through regulating the role of miR‐143‐3p and PI3K‐Akt insulin signal pathway.

**Methods**: Circ_0001982 was selected through bioinformatics methods and literature review, and detected in the serum of MetS patients and in the inguinal and epididymal adipose tissues of obesity‐induced IR model mice by qRT‐PCR with 12 other circRNAs. The biological function of circ_0001982 in glucose uptake activity and insulin resistance was measured using a fluorescent D‐glucose analogue (2‐NBDG) and PI3K‐Akt activation in differentiated 3T3‐L1 preadipocytes. The miRNA in vivo precipitation (miRIP) test was used to find its target miRNAs.

**Results**: The expression of circ_0001982 was significantly reduced in the serum of MetS patients and adipose tissues of obesity‐induced IR model mice (both *P* \< 0.01). Downregulation of circ_0001982 by siRNAs impaired the glucose uptake activity through the 2‐NBDG measurement and inhibited the PI3K‐Akt insulin signal pathway. StarBase&circBase databases prediction and RNAhybrid analysis found that it had a binding site of miR‐143‐3p which was highly abundant in the serum of MetS patients and could promote IR in the target organs of insulin action in our previous work. MiRIP test verified circ_0001982 could bind to miR‐143‐3p. Downregulation of circ_0001982 increased the expression of miR‐143‐3p and reduced its target gene IGF2R.

**Conclusion**: The expression of circ_0001982 is reduced in MetS patients and obese mice, and its low abundance impairs glucose uptake and insulin‐stimulated PI3K‐Akt activation. The possible mechanism of this effect is that circ_0001982 may play a role as a sponge of miR‐143‐3p and its regulation of the target gene IGF2R. We hope to further explore the feasibility of protecting obesity‐induced IR by over‐expressing circ_0001982 and provide a new drug target for the prevention and treatment of IR presence in MetS patients.
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**Purpose**: Type 2 diabetes (T2D) often dwarfs other types of diabetes. Increasing evidence shows that 93% of all diabetes of the exocrine pancreas (DEP) cases, thought to be the second most common type of diabetes, are misdiagnosed as T2D. New‐onset prediabetes and diabetes after acute pancreatitis (NODAP) (with acute pancreatitis being the most common gastrointestinal condition) contributes to 61% of all DEP cases. However, investigation of the pathogenetic milieu underlying NODAP has been meagre, with no evidence‐based guidelines on whether treatment of DEP should differ from T2D. This study investigated pancreatic hormone responses to mixed meal test, in particular changes in insulin secretion and sensitivity in individuals with NODAP versus healthy controls.

**Methods**: A total of 29 cases and 29 age‐ and sex‐matched controls were recruited. All participants were given a 12 oz. Boost^®^ drink; blood samples were collected before and after stimulation to measure insulin, C‐peptide, glucagon, and pancreatic polypeptide (PP). Several indices of insulin sensitivity (HOMA‐IS, 1/fasting insulin, Raynaud, and Matsuda) and of insulin secretion (HOMA‐β, Stumvoll, insulinogenic index 30' and 60') were calculated. Repeated measures and area under curve (AUC) analyses were conducted in unadjusted and adjusted (BMI) models.

**Results**: Insulin and C‐peptide levels were significantly higher in cases compared to controls at fasting and during the mixed meal test in both the unadjusted (*P* \< 0001) and adjusted (*P* \< 0001) models. AUC for insulin and C‐peptide were also significantly higher in cases (*P* = 0.001). HOMA‐IS (*P* = 0.005), 1/fasting insulin (*P* = 0.018), Raynaud index (*P* = 0.018), and Matsuda index (*P* = 0.021) were significantly lower in cases, while HOMA‐β (*P* = 0.028) and Stumvoll index (*P* = 0.013) were significantly higher. Insulinogenic index 30′ and 60′ did not differ significantly between the groups. Glucagon and PP did not differ significantly between the study groups at fasting and during the mixed meal test in both models.

**Conclusion**: Decreased insulin sensitivity, β‐cell compensation, and no significant change in secretion of glucagon and PP characterize NODAP. The above findings may help develop an evidence‐based protocol with a view to optimizing control of glucose homeostasis in individuals with NODAP.
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**H. Wang, Y. Bi and D. Zhu**

Department of Endocrinology, Drum Tower Hospital Affiliated To Nanjing University Medical School, Nanjing, China

**Aims**: Disturbance of intestinal homeostasis, characterized by small intestinal hyperplasia and dysbiosis of gut microbiota, promotes the development of type 2 diabetes. Although early insulin therapy has been demonstrated to improve insulin sensitivity in type 2 diabetic patients through multiple mechanisms, its effect on the intestinal microenvironment has not been investigated.

**Methods**: Male C57BL/6 mice, fed a high‐fat diet (HFD) for 8 weeks, were treated with insulin for 3 weeks to evaluate the effect of early insulin therapy on intestinal function and proliferation. Next‐generation sequencing and multivariate analysis were utilized to evaluate the structural changes of gut microbiota. FHs 74 int cells were used to assess the direct role of insulin on cell proliferation.

**Results**: We found that increased intestinal length, villi length, crypt depth, and impaired intestinal barrier integrity were significantly reversed after insulin therapy. In addition, insulin therapy notably decreased expression of cyclin D1 and proliferating cell nuclear antigen (PCNA) in intestine tissue, while expression of cleaved‐caspase3 was increased. In vitro growth curve assay further showed that insulin exhibited no effect on proliferation potential of intestinal epithelial cells. More importantly, insulin therapy dramatically shifted the overall structure of the HFD‐disrupted gut microbiota toward that of mice fed a normal diet and altered the gut microbial composition. The abundances of 54 operational taxonomic units (OTUs) were altered by insulin therapy. Twenty‐two altered OTUs were significantly correlated with one or more intestinal proliferation associated parameters and designated 'functionally relevant phylotypes'.

**Conclusion**: For the first time, our data showed that early insulin therapy improves insulin sensitivity in part through modulation of intestinal homeostasis disturbance induced by overnutrition. Importantly, stain‐specific impacts on intestinal proliferation associated phylotypes of gut microbiota may represent a mechanism for insulin therapy related metabolic improvement.
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**A. K.‐f. Chong**

University of Southern Queensland, Toowoomba, Australia

**Purpose**: Currently, the population percentage of diabetics suffering Diabetic Peripheral Neuropathy (DPN) and foot‐drop gait anomaly was estimates as 15% in the United States. The onset of foot‐drop could not be detected until symptoms could be observed visually, patient falling or patient experiencing painful gait issues and medical tests. This research showed that by utilising the plantar‐pressure characteristics of DPN drop‐foot gait, a set of index could be developed for the severity of DPN.

**Methods**: The protocol involved the recruitment of older diabetic adults who were confirmed to have diabetic peripheral neuropathy (DPN) at two local hospitals in Malaysia. Also, older diabetic adults who have no DPN were recruited. Soft targets were placed on the plantar surface at the heel and at the second metatarsal areas. A set of prototype stencils were used to position the targets. Subjects wore shoes with in‐sole pressure sensors (TekScan) and walked on a straight line for roughly 20 steps and repeated six times. Based on the heel target position, the plantar distance covered from heel‐down along the foot‐path for a specific period of time was calculated and was called Plantar distance at the heel (PDH). Then, the amount of time it took to cover a quarter of the foot‐path from heel‐down and the amount of time it took to cover the foot‐path from the second metatarsal head to toe‐off were called Time at heel (TAH) and Time at push‐off (TAP), respectively. The results of the study are provided in Table I. The PDH covered by DPN subjects were significantly larger those of non‐DPN subjects in all cases. By taking the ratio between PDH and TAH, an index could be determined successfully.

**Conclusion**: With the discovery of these measures, drop‐foot anomaly could be determined at an early stage; thus, DPN patients could have access to orthotics promptly, hence avoiding falling and other adverse effects such as plantar ulcer development, reluctance to walk and lack of enthusiasm for physical exercise.
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**T. Osaka^1^, Y. Hashimoto^2^, M. Hamaguchi^2^, T. Kojima^3^, A. Obora^3^ and M. Fukui^2^**

^1^Ayabe Munipicipal Hospital, Ayabe, Japan^2^Kyoto Prefectural University of Medicine, Kyoto, Japan^3^Murakami Memorial Hospital, Gifu, Japan

**Background & Aims**

As a prevention for type 2 diabetes, it is important to diagnose impaired glucose tolerance (IGT) by 75 g oral glucose tolerance test (OGTT). It is known that IGT continues to type 2 diabetes. However, the predictor of remission of IGT has not clarified yet; thus, we aimed to elucidate the predictor of remission of IGT in this study.

**Methods**: In this cohort study, we included the participants, who received 75 g OGTT 2 or more times, and IGT at baseline examination. We excluded the patients who took antidiabetic medication. IGT was defined as 2‐hour postload plasma glucose (PPG) 7.8 mmol/l to 11.1 mmol/L. Between a remission of IGT and not were compared using t‐test and Pearson\'s chi‐squared test. To evaluate the predictor of a remission of IGT, we used Cox proportional hazard regression model after adjusting for age, gender, BMI, alcohol, exercise, smoking, FPG and 2‐h PPG.

**Results**: Among 227 participants whom male were 150 (82.4 %), median age 54.5 years, mean BMI 24.2 kg/m2, mean fasting plasma glucose (FPG) 6.1 mmol/L, 1‐h PPG 11.1 mmol/L, 2‐h 10.5 mmol/L and hemoglobin A1c 5.8 %, 80 participants (35.2 %) reached a remission of IGT, during a mean follow‐up of 6.2 years. No remission of IGT was 102 participants (64.8 %) including 74 (72.5 %) participants developing to diabetes. Age, FPG, 1‐h PPG, 2‐h PPG and hemoglobin A1c of the participants with a remission of IGT were lower than those of the participants with no remission of IGT. One‐hour PPG was associated with a remission of IGT after covariance (HR 0.84, 95% CI 0.75--0.94, *P* = 0.002).

**Conclusions**: Low 1‐hour PPG level was a good predictor for a remission of IGT. Participants with high 1‐hour PPG should receive lifestyle guidance and close follow‐up.
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Brown adipose tissue (BAT) is an attractive therapeutic target for combatting obesity and diabetes owing to its ability to increase energy and glucose metabolism. Although human BAT activity has been mainly evaluated via 18‐fluorodeoxyglucose‐positron emission tomography/computed tomography (^18^FDG‐PET/CT), this method has some limitations, such as radiation exposure, need for a 2‐h cold exposure, and enormous costs of device. Therefore, we attempted to non‐invasively evaluate BAT activity using infrared thermography (IRT) and determined whether IRT can be used as an alternative to ^18^FDG‐PET/CT. The BAT activity of 24 healthy young men was assessed by ^18^FDG‐PET/CT. Skin temperature (ST) at the supraclavicular and subclavicular regions, which are close to and far away from underlying BAT, respectively, were monitored using IRT at 27℃, during 2‐h cold exposure at 19°C with light clothing, or during 5‐min hand immersion into 18°C water. The IRT index was calculated as (supraclavicular ST -- subclavicular ST) / subclavicular ST × 100%. The relationship between the IRT index and BAT activity and the accuracy of IRT were analyzed by Pearson\'s correlation and receiver operating characteristic curve (ROC) analyses, respectively. The IRT index was highly correlated with the BAT activity when monitored after cold exposure (r = 0.76), but poorly at 27℃ (r = 0.10) and after water immersion (r = 0.40). ROC analysis revealed that the accuracy of BAT detection was 85.4% after cold exposure. The IRT index plateaued 20 min after cold exposure, suggesting long‐term cold exposure is not always necessary. Our results thus indicate that the IRT method combined with short‐term cold exposure is a non‐invasive alternative to ^18^FDG‐PET/CT for evaluating BAT activity, at least in young healthy men.
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Insulin resistance induces neuronal dysfunctions through disrupting metabolic coupling between neurons and astrocytes {#jdi12938-sec-0124}
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**X. Zhao, Y. Cao, X. Gang, Y. Lv and G. Wang**

The First Hospital of Jilin University, Changchun, China

**Background and Aim**: Clinical studies have suggested an intimate link between type 2 diabetes mellitus, insulin resistance and cognitive dysfunction, but there are significant gaps in our knowledge of the mechanisms underlying this relationship. The metabolic coupling between neuron and astrocyte mainly refers to the transportation of energetics and metabolites such as lactate and glutamate, which can protect neurons from damage under pathological conditions. In present study, we applied a neuron‐astrocyte co‐culture system to explore the metabolic interactions between these cells and detected the alterations of metabolic coupling in palmitic acid‐induced insulin resistance. Furthermore, we used metformin, pioglitazone, linagliptin and GLP‐1 receptor agonist as intervention drugs to discover the impact of hypoglycemic drugs on the metabolic coupling between neuron and astrocyte under IR condition.

**Methods**: We cultured HT22 hippocampal cells with GL261 glioma cells in a co‐culture system which allows the cells to share nutrients through the media without physical contact. The morphological changes were examined by HE staining; the apoptosis and aging were also examined. And neuronal synaptic plasticity was examined by the protein expressions of PSD95, BDNF, Arc and Synapsin1. To detect metabolic coupling between two cells, the energy substrates and related transporters (MCT1, MCT2, MCT4) were detected.

**Results**: In neuron‐astrocyte co‐culture system, palmitic acid‐induced insulin resistance caused significant neuronal morphological changes, accelerated neuronal apoptosis and aging. The expressions of neuronal synaptic plasticity related proteins such as PSD95, BDNF, Arc and Synapsin1 were decreased. Under insulin‐resistant condition, lactate and glutamate levels increased in neuron cells (*P* \< 0.05). Consistently, MCT1, MCT2 and MCT4 protein expressions were decreased, indicating an impaired transportation of lactate from astrocytes to neurons (*P* \< 0.05). Hypoglycemic drugs (metformin, pioglitazone, linagliptin and GLP‐1 receptor agonist) significantly restored the altered metabolic coupling lactate and glutamate levels as well as the protein expression of MCT1, MCT2, MCT4 (*P* \< 0.05).

**Conclusions**: Palmitic acid‐induced insulin resistance influenced neuronal morphology and impaired synaptic plasticity through disrupting the metabolic coupling between neurons and astrocytes. Hypoglycemic drugs might restore the altered metabolic coupling and improve neuronal synaptic plasticity, which sheds light on a new target for hypoglycemic drugs on improving cognitive decline.
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Glycine protects against pancreatic β‐cell apoptosis and inflammation by inhibiting multiple signalling pathways {#jdi12938-sec-0126}
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**L. Chen, J. Zhang, Z. Wang, J. Li, D. Zhao and X. Guo**

Peking University First Hospital, Beijing, China

Inflammation is a feature of diabetes that is associated with apoptosis and dysfunction of pancreatic β‐cells. Glycine has been shown to attenuate the inflammatory response in various cell types and in patients with type 2 diabetes; however, its effect in regulating β‐cell inflammatory responses remains unknown. Thus, we investigated whether glycine prevents apoptosis and inflammation of β‐cells. In streptozotocin‐induced diabetic rats, glycine was shown to significantly reduce inflammatory factor levels in the plasma and pancreatic tissue; glycine also restored glucose‐stimulated insulin secretion and decreased β‐cell apoptosis in INS‐1 cells cultured with high glucose or inflammatory factors (IL‐1β, TNF‐α and IFN‐γ). Mechanistically, glycine blocked the activation of NF‐κB, JNK and p38MAPK by high glucose, and this effect of glycine was blocked by glycine receptor inhibitor or glycine transporter 1 inhibitor. Moreover, glycine attenuated the ability of high glucose to reduce PI3K/Akt and AMPK signaling, but this was not dependent on the glycine receptor or glycine transporter 1. Collectively, these results uncover novel mechanisms for the beneficial effects of glycine on β‐cell inflammation and viability, highlighting the therapeutic potential of glycine for diabetes.
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**M. A. Garstka^1^, S. Liu^1^, Y. Wen^2^, Y. Liu^1^ and Z. Ouyang^2^**

^1^Core Research Lab of the Second Affiliated Hospital of Xi\'an Jiaotong University, Xi\'an, China^2^Department of Biological Science and Bioengineering, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi\'an Jiaotong University, Xi\'an, China

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease, in which auto‐reactive CD8+ T cells destroy pancreatic β cells. Diagnosed with which, patients cannot produce insulin and eventually cannot control blood glucose levels. In T1DM CD8+ T cells, auto‐reactivity is caused by a self‐antigen presentation by certain major histocompatibility complex (MHC) class I molecules. HLA‐B\*39:06 is the most predisposing MHC class I allele, independently of the long‐known MHC class II haplotypes. Moreover, HLA‐B\*39:06 is associated with an early age of T1DM onset. The reasons for the association of HLA‐B\*39 with T1DM remain unknown. To decipher the underlying molecular mechanisms, we determined the crystal structures of T1DM‐predisposing B\*39:06 and closely related T1DM‐protective B\*38:01 subtypes complexed with the same insulin‐derived nonapeptide. We expressed and characterized both subtypes in cell lines under normal and ER stress conditions using flow cytometry confocal microscopy and western blot analyses. B\*39:06 showed more stable nonapeptide binding. In both subtypes, the nonapeptide bound in a conformation almost identical at the N and C termini, emphasizing the importance of the primary anchors for complex stability. However, binding of the secondary anchor differed, as well as the conformation of the exposed residues that are potential T cell receptor contact sites, with B\*39:06 binding nonapeptide in more closed conformation. Moreover, B\*39:06 localized at the cell surface and in the late endosomes. The 25°C block or chloroquine treatment decreased endosomal localization of B\*39:06. This suggests that B\*39:06 can travel to the cell surface with sub‐optimal antigen load and upon antigen dissociation is endocytosed and targeted for endosomal degradation. Our data suggest that T1DM‐predisposing MHC I allele is more stable than T1DM‐protective allele and can bind sub‐optimal peptides. This may cause auto‐reactivity in the inflammatory context found in T1DM where such sub‐optimal peptides may be presented locally at a higher dose.
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**H. Mohamed**

Weill Cornell Medicine, Doha, Qatar

**Introduction**: Chronic diabetic foot ulcers (CDFU) are associated with increased morbidity, mortality especially in developing countries. The role of natural honey on wound healing in various etiology wounds at primary care level has not been previously studied. In this study, we hypothesize that natural honey is efficacious, safe and cost effective in chronic wound healing.

**Methods**: We conducted a 5‐year retrospective cohort study with prospective long‐term follow‐up of all patients with (CDFU) who presented to Umgwalinah Health Centre, Doha, Qatar. Average follow‐up was 1 year. failure of natural honey was the main outcome measure. Independent predictor variables were selected by logistic regression analysis.

**Results**: A total of 126 patients with diabetes were managed for various foot lesions as follows. Five patients (4%) of 126 underwent immediate amputation. Natural honey treatment was successful for 91 (92.86%) of 98 neuropathic ulcers, 3 (30%) of 10 neuro‐ischemic ulcer, 2 (66%) of 3 charcot foot ulceration,4 (100%) of 4 patients with second degree burns & 6 (100%) of 6 traumatic foot ulceration or (*p* \< 0.001, Chi2 for trend). Independent factors predictive of failure to heal were presence of osteomyelitis (odds ratio \[OR\]=1.6, 95% confidence interval \[CI\], 1.0--1.3), increased hemoglobin A1c level (OR = 1.002; 95% CI, 1.2--1.3), severe peripheral vascular disease (OR = 1.0,95% CI, 1.0--1.03), prior hospitalization for(CDFU) (OR = 1.4; 95%CI, 1.2--1.6) & gangrenous lesion(OR = 1.7; 95% CI, 1.3--2.1). No side effects were reported and there was a high level of satisfaction (patients and staff).

**Conclusion**: Our data revealed that primary care based management of (CDFU) using natural honey is efficacious, safe and acceptable. These findings may lead to a substantial reduction in the cost of (CDFU) in the third world. Future comparative studies utilizing randomized controlled trials must be conducted in order to accurately assess the efficacy of natural honey in managing (CDFU).
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**Background**: Renal function loss is the sign of diabetic nephropathy and the risk for adverse renal events. The earlier detection of renal function decline can lead to earlier intensive treatment, which will result in slowing the progression to end‐stage renal disease (ESRD).

**Aim**: The aim of the study was to examine whether the spectrum characteristic of the radial pressure wave is associated with the tradition index of renal function, including albumin‐creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR), in patients with Type 2 diabetes.

**Method**: Radial pressure wave was measured by a piezoresistive sensor in 1956 (Male: 1167, Female: 789) Type 2 diabetic patients recruited from the Division of Endocrinology & Metabolism of Zhongxiao Branch of Taipei City Hospital. For each patient, spectrum analysis of radial pressure wave was calculated and transformed into harmonics of amplitude(Cn), Phase(Pn), and variations of harmonic amplitudes(Cn_CV). Different level of renal function loss according to ACR and eGFR was examined.

**Results**: The means of C1, C4_CV of radial pulse increased along with the increment of ACR, from normal (C1: 0.97 ± 0.13, C4_CV: 8.6% ± 6.8%) through microalbuminuria (C1: 0.98 ± 0.13, C4_CV: 9.3% ± 8.0%) to macroalbuminuria (C1: 0.99 ± 0.14, *P* \< 0.1; C4_CV: 9.3% ± 8.0%, *P* \< 0.05), whereas P2 decreased with the increment of ACR (*P* \< 0.05). The means of C4_CV of radial pulse increased when the EGFR decreased from stage 1 (C4_CV: 8.3% ± 6.5%) to stage 5 (C4_CV: 13.5% ± 7.3%, *P* \< 0.01) of renal disease, whereas P2 decreased when EGFR decreased (*P* \< 0.01).

**Discussion**: The preliminary findings from the study identified the C1, C4_CV, and P2 of radial pressure wave could be a set of important predictors for early diagnosis of renal function loss in type 2 diabetic patients. The greater values of C1 and C4_CV and the lower values of P2 may indicate the need for further investigation of renal function.
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**B. Cao**

Department of Endocrinology, Jinling Hospital

**Objective**: The purpose of the present study was to investigate the potential associations between albuminuria and estimated glomerular filtration rate (eGFR) and sudomotor function in Chinese type 2 diabetes.

**Research design and Methods**: We randomly recruited 263 patients with type 2 diabetes who were hospitalized at the Department of Endocrinology, Nanjing Jinling Hospital from March 2016 to May 2017. The patients median age was 54.63 ± 12.42 years. ESC expressed in microSiemens (μS) was measured using the Sudoscan^®^ device to assess sudomotor function.

**Results**: The mean hands electrochemical skin conductance (HESC) and the mean feet electrochemical skin conductance (FESC) were negatively correlated with urinary albumin‐to‐creatinine ratio (UACR) and positively associated with eGFR (*P* \< 0.05 for all); Both hands asymmetry ratio value (HASYM) and feet asymmetry ratio value (FASYM) were positively correlated with urinary albumin‐to‐creatinine ratio (UACR) and negatively associated with eGFR (*P* \< 0.05 for all). Even in the UACR \< 30 mg/g and eGFR ≥90 ml/min/1.73 m^2^ groups, the relationships above still existed. In the multivariate linear stepwise regression analysis with HESC and FESC as the dependent variables, UACR and eGFR were the major independent contributors to both HESC and FESC (*P* \< 0.01 for all), after adjusting for age, time since the diagnosis of diabetes, gender, blood pressure, BMI, lipid profiles and HbA1c.

**Conclusions**: Our observations suggest that both HESC and FESC were negatively correlated with UACR and positively associated with eGFR. It is valuable for clinicians to assess sudomotor function in type 2 diabetes, especially in the UACR \< 30 mg/g and eGFR ≥90 ml/min/1.73 m^2^ groups.
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**Background and aims**: Cold atmospheric plasma (CAP) interacted with tissue and had potential effects on wound healing and tissue regeneration. The aim of this study was to investigate the efficacy and safety of CAP as a novel therapy for diabetic wounds in vitro and vivo.

**Materials and methods**: The plasma consists of ionized helium gas that is produced by a high‐voltage (8.5 kV) and high‐frequency (17 kHz) power supply. Eight‐week‐old male db/db mice were treated with helium gas (control group), 90′s CAP (low‐dose group) and 180′s CAP (medium‐dose group). Mice were treated and observed for 2 weeks. Skin samples around wound in 3, 7, 14 days and blood samples were collected and analyzed in three groups.

**Results**: We found that after 14 days of treatment, CAP could obviously promote diabetic wound healing because of inhibiting inflammation and enhancing angiogenesis. Wound‐closure rates were significantly faster in the low‐does group and high‐does groups than in the control group. Meanwhile, the protein expression of IL‐6, TNF‐α, iNOS and SOD in two CAP groups was significantly decreased than those in control group and the protein expression of VEGF, TGF‐β in two CAP groups was significantly increased compared to those in control group (all *P* \< 0.05), these data showing a good agreement with the change in mRNA level (all *P* \< 0.05). Additionally, there was no difference in histological observation and the level of serum ALT, AST, BUN, Cr and white blood cell among CAP groups and control group.

**Conclusion**: CAP treatment improves diabetic wound healing by inhibiting inflammation and enhancing angiogenesis, involving several proteins signaling. And no relevant side effects on liver and kidney were detected.
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**Aims**: The study aimed to investigate alterations in glycated hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5‐anhydroglucitol (1,5‐AG) in Chinese first‐degree relatives of individuals with diabetes (FDR) in pursuit of an index for early screening of glucose metabolism disturbance.

**Methods**: A total of 467 participants (age range: 20--78 years) with normal weight and normal glucose tolerance, as determined by a 75‐g oral glucose tolerance test, were enrolled. HbA1c was measured using high‐performance liquid chromatography. Serum GA and 1,5‐AG levels were determined by enzymatic methods. Serum insulin levels were measured using an electrochemiluminescence immunoassay.

**Results**: The study population included 208 FDR and 259 non‐FDR. Serum 1,5‐AG levels were lower in FDR than that in non‐FDR (20.4 ± 7.5 μg/ml versus 23.8 ± 8.3 μg/ml, *P* \< 0.001), but HbA1c and GA levels did not differ between them (*P* = 0.835 and 0.469, respectively). Logistic regression analysis revealed an independent relationship between a first‐degree family history of diabetes and reduced serum 1,5‐AG levels (odds ratio = 0.944, *P* \< 0.001). Multiple regression analysis showed that a first‐degree family history of diabetes (*β* = --3.041, *P* \< 0.001) and insulinogenic index (*β* = 0.081, *P* = 0.001) were independently associated with serum 1,5‐AG levels.

**Conclusions**: In a Chinese population with normal glucose tolerance, serum 1,5‐AG levels were lower among FDR and serum 1,5‐AG levels were independently associated with FDR status. For FDR, serum 1,5‐AG levels were more sensitive than HbA1c or GA levels to early‐phase abnormality in glucose metabolism.
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**Objectives**: We aimed to investigate whether fibroblast growth factor 21 (FGF21) can be used to identify the future development of major adverse cardiovascular events (MACEs).

**Methods**: Two hundred and fifty‐three patients who received investigation at baseline finished subsequent follow‐up, 234 of whom had complete follow‐up information within a median period of 4.8 years. Independent predictors of MACEs were identified using cox proportional hazards regression analysis.

**Results**: Five patients had non‐cardiovascular‐related deaths and were excluded from the analysis. Of 229 patients finally enrolled in the analysis, 27 of 60 without coronary artery disease (CAD) at baseline experienced a MACE, and 132 of 169 patients with CAD at baseline experienced a MACE. Among patients with CAD at baseline, serum FGF21 levels were significantly higher in patients with MACEs (*P* \< 0.05) than in patients without MACEs. Kaplan‐Meier survival analysis showed a significantly lower event‐free survival (*P* = 0.001) among patients with a higher serum FGF21 level than in those with a lower serum FGF21 level. Further Cox proportional hazards regression analysis, including the multiple confounding risk factors for cardiovascular disease, showed that serum FGF21 was one of the independent predictors of the occurrence of MACEs.

**Conclusions**: In patients with CAD at baseline, an elevated serum FGF21 level was associated with the development of a MACE in the future.

This study was funded by Translational Medicine Innovation Foundation of Shanghai Jiao Tong University School of Medicine (15ZH4006).
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**Background**: Haptoglobin (Hp) functions as an antioxidant by binding with haemoglobin. We investigated whether serum Hp has a causal effect on macroangiopathy via Mendelian randomization (MR) analysis with common variants of the Hp gene in Chinese patients with type 2 diabetes.

**Methods**: A total of 5687 type 2 diabetes patients were recruited and genotyped for the Hp gene. Clinical features and vascular imaging tests were applied to diagnose macroangiopathy. The association between common Hp genotypes and macroangiopathy was analyzed in the whole population. Serum Hp levels were measured by enzyme‐linked immunosorbent assay in a subset of 935 patients. We individually analyzed the correlations among Hp levels, Hp genotypes and macroangiopathy. Further, 8‐hydroxy‐2′deoxyguanosine (8‐OHdG), an oxidative marker of DNA damage, was examined to evaluate the levels of oxidative stress.

**Results**: Common Hp genotypes were correlated with macroangiopathy (OR = 1.140 \[95% CI 1.005-- 1.293\], *P* = 0.0410 for the Hp 1 allele). Serum Hp levels were associated with both common Hp genotypes (*P* = 3.55 × 10^−31^) and macroangiopathy (OR = 2.123 \[95% CI 1.098--4.102\], *P* = 0.0252) in the subset of 935 patients. In the MR analysis, the directional trends of the observed and predicted relationships between common Hp genotypes and macroangiopathy were the same (OR 1.357 and 1.130, respectively). Furthermore, common Hp genotypes and Hp levels were associated with serum 8‐OHdG levels (*P* = 0.0001 and 0.0084, respectively).

**Conclusions**: Our study provides evidence for a causal relationship between serum Hp levels and macroangiopathy in Chinese type 2 diabetes patients by MR analysis.
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**Purpose**: Diabetic Retinopathy (DR) is a significant cause for blindness, and also a major microvascular complication of diabetes mellitus. The prevalence is estimated to range from 24.7% to 37.5% among T2DM patients. However, still lack of nationwide survey on the prevalence of DR in China. The present study is designed to determine the prevalence of DR in China.

**Method**: China DR Screening and Prophylaxis Project was initiated in January 2017. Sponsored by Chinese Society of Microcirculation, Conducted in 242 hospitals across 26 provinces in China. We introduced an AI‐based DR screening cloud platform, AutoEye. Retinoscopy was performed on all patients screened. Diagnosis of DR is made with AutoEye.

**Result**: Up to June 2018, 300,746 DM patients were screened for DR. Among of these patients, 145,056 patients were remotely assessed by ophthalmologists and 155,690 patients were AI‐based automatically assessed. Mean age of the screened patients was 55.36 years old, and 53.62% were male. 106,860 (35.53%) patients were from Southern China and 193,886 (64.47%) patients were from Northern China. Based on AutoEye, 111,108 (36.94%) DM patients were diagnosed with DR with a mean age of 56.50 yrs. The prevalence of DR in Chinese DM patients was 36.94%. The prevalence in males and females was 37.11% (59,841 patients) vs 36.75% (51,267 patients), respectively, with no significant gender difference. Also found that DR prevalence in Northern area (37.70%, 73,089 patients) was significantly higher than in Southern area (35.58%, 38,019 patients). DR prevalence was related to age. There was a significantly higher DR prevalence for patients older than 43 years, especially in patients aged 58 yrs to 72 yrs (39.79%). Another factor associated with fasting plasma glucose level (FPG) was examined. DR prevalence (close to 41%) was higher among patients with an FPG \>7.0 mmol/L.

**Conclusion**: The present survey with an AI‐based automatic screening system shows that DR prevalence in Chinese diabetic patient is up to 36.94%. Age and FPG level are risk factors for DR. Early screening is strongly recommended for DM patients, especially for those older than 43 yrs.
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**Background**: The prevalence of Type 2 Diabetes Mellitus (T2DM) has reached epidemic level in both developed and developing countries globally. Vascular complications are the main causes of morbidity and mortality in T2DM. Peripheral Arterial Disease (PAD) occurs in about 15% of adults with T2DM. Risk factors of incident PAD are relatively unexplored. This prospective study aims to determine baseline predictors of incident PAD.

**Methods**: We consecutively enrolled adult patients (*n* = 2057) with T2D, seen at our institution\'s Diabetes Centre and a community medical centre in Singapore (August2011--March2014). 1493 of them made a repeat visit (3.2 yrs median follow‐up). Anthropometric data, fasting blood, urine were collected for biochemistry and urine albumin/creatinine measurements (uACR). At least 3 measurements were taken for blood pressure, from participants, using an automated blood pressure monitor. Estimated GFR (eGFR) was calculated using CKD‐EPI equation. PAD was defined to be present if the lower Ankle Brachial Index \<0.9 or patients who had previous amputations. Patients with ABI \> 1.4 were excluded from analyses (due to calcified vessels). Multivariable cox regression was used to examine independent predictors of incident PAD (STATA).

**Results**: Baseline age: (57.4 ± 10.8) yrs, diabetes duration: (11.3 ± 9.1) yrs, HbA1c: (7.78 ± 1.33) mmol/l. Prevalence of PAD at baseline was 13.4% (*n* = 258). On follow‐up, (*n* = 104) patients died, (*n* = 460) patients did not follow‐up various reasons (withdrew, uncontactable), (*n* = 69) unavailable readings and *n* = 50 calcified vessels. Of 975 patients without PAD at baseline, *n* = 51 (5.2%) developed PAD, *n* = 27 (2.8%) had readings more than 1.4 and were excluded. Compared to those who did not develop PAD, SBP (per 10unit) (β = 0.113, SE = 0.056, *P* = 0.041), older age (β = 0.0342, SE = 0.0134, *P* = 0.011), log‐transformed uACR (β = 0.302, SE = 0.125, *P* = 0.016), Indian ethnicity (reference: Chinese) HR (95% CI): 1.803 (1.132‐ 2.871), *P* = 0.013 and baseline current smokers HR (95% CI): 2.618 (1.385--4.948), *P* = 0.003 were significant predictors of incident PAD, after adjustment for gender, BMI, eGFR, duration of diabetes, HbA1c and LDL‐c.

**Discussion & Conclusion**: Older age, Indian ethnicity, smoking status, blood pressure and urinary ACR predicts incident PAD. Improvements in lifestyle such as exercise or medication adherence to reduce blood pressure; smoking cessation efforts may reduce incidence of PAD. Longer duration of follow‐up is required to observe if other risk factors are involved.
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**Objective**: The purpose of this paper was to explore the relationship between thyroid function and the correlation of major vascular lesions in newly diagnosed T2DM, evaluation of different levels of thyroid function of complications related to diabetes, further clarify the importance of the management of thyroid function in patients with diabetes.

**Methods**: A total of 208 cases with newly diagnosed T2DM patients were collected in November 2016‐March 2018 in our hospital endocrinology inpatient or outpatient, all the patients were in accordance with the 1999 world health organization (WHO) diagnostic criteria for type 2 diabetes. Patients with thyroid hormone abnormalities (mainly low FT3 syndrome, hyperthyroidism and thyroidectomy), the absence of thyroid related antibodies and related complications were removed; finally, a total of 161 newly diagnosed T2DM patients were selected. Of TSH stratification: \<2.5 mIU/l divided into group A, 2.5--4.2 mIU/l for group B, \>4.2 mIU/l for group C, analysis of thyroid function level of first diagnosis in patients with T2DM patients with the biochemical indicators (FPG, TG, TC, HbAlc, TSH, TGAb, TPOAb, CIMT, etc.) and the influence of large vascular lesions, and analyze the correlation between TSH and his index.

**Results**: It was found that men\'s fasting blood glucose, high‐density lipoprotein, uric acid and creatinine were all higher than females, and the difference was statistically significant (*P* \< 0.05) by gender groups. The positive rate of arterial plaque in lower extremity was 14.9% (24cases) and 9% (6cases), and the difference was statistically significant (*P* = 0.006). The positive rate of carotid artery plaques was 38.3% (70 cases) and 15.6% (28 cases), and the difference was statistically significant (*P* = 0.005). The risk of concurrent hypertension was also significantly higher in men than in women, with 39.4% in men and 13.4% in women, and statistically significant difference (*P* = 0.001). 2. Comparison between groups of subclinical hypothyroidism group (group C) of triglyceride, total cholesterol, common carotid artery intima‐media thickness were higher than group A and group B, and the difference was statistically significant (*P* \< 0.05); The high‐density lipoprotein in group C was lower than group B, and the difference was statistically significant (*P* \< 0.05). The low‐density lipoprotein in group B and C was higher than group A, and the difference was statistically significant (*P* \< 0.05). Fasting blood glucose and glycosylated hemoglobin C were higher than those in the other two groups, but the difference was not statistically significant (*P *\> 0.05). 3. Comparison between the three groups found that with the increase of TSH, TGAb positive rate also will increase, and the difference was statistically significant (*P* \< 0.05), although found no statistically significant difference, the positive rate of diabetes mellitus and thyroid peroxidase antibody in subclinical hypothyroidism group was still higher than that of group A and group B.

**Conclusion**: 1. The TSH level of the patients was closely related to the thickness of the blood lipid and carotid artery and the large vascular lesions. When TSH \> 4.2 mIU/l, the risk of large vessel lesions increased. 2. In newly diagnosed T2DM, the incidence rate was 11.2%, and the positive rate of thyroid hormone antibody (TGAb and TPOAb positive) was 13.7%. Routine screening of thyroid hormones and associated antibodies in T2DM patients is necessary.
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**Objective**: The ileum‐derived fibroblast growth factor 19 (FGF19) plays key roles in hepatic glucose homeostasis in animals in an insulin‐independent manner. Here, we analyzed the association of FGF19 with glucose effectiveness \[GE, the ability of glucose to enhance its own disposal and suppress hepatic glucose production (HGP) insulin independently\], as well as HGP in Chinese subjects.

**Methods**: GE was measured by frequently sampled intravenous glucose tolerance test (FSIVGTT) in 31 normal glucose tolerance (NGT), 34 isolated‐impaired glucose tolerance and 31 isolated‐impaired fasting glucose (I‐IFG) subjects. The oral glucose tolerance test‐derived surrogate of GE (oGE) was determined in 56 NGT, 23 I‐IFG, 36 combined glucose intolerance (CGI) and 83 type 2 diabetes (T2DM) subjects. HGP was assessed by labelled (\[3‐^3^H\]‐glucose) hyperinsulinemic‐euglycemic clamp in 14 NGT subjects. Insulin secretion and sensitivity were calculated by the hyperglycemic and hyperinsulinemic‐euglycemic clamps in a subgroup of 14 NGT subjects. Serum FGF19 levels were determined by ELISA.

**Results**: I‐IFG subjects (0.023 ± 0.001 min^−1^) had significantly lower GE than NGT subjects (0.029 ± 0.009 min^−1^) (*P* \< 0.05). However, no significant difference in GE was observed between I‐IGT (0.025 ± 0.01 min^−1^) and NGT subjects. Similar trend was also found in fasting serum FGF19 levels. FGF19 positively correlated with GE (r = 0.247, *P* = 0.015) as determined by FSIVGTT. The result was further confirmed by oGE (r = 0.261, *P* \< 0.001). Both FGF19 (r = −0.228, *P* = 0.025) and GE (r = −0.215, *P* = 0.035) were negatively associated with fasting plasma glucose (FPG), but the association between FGF19 and FPG no longer existed after adjusting for GE (r = −0.191, *P* = 0.064). FGF19 was negatively associated with basal HGP (r = −0.697, *P* = 0.006). However, the correlation between FGF19 and insulin secretion and sensitivity was not found.

**Conclusion**: FGF19 levels are associated positively with GE and negatively with HGP. The increase of FPG in human is at least partially due to the decrease of FGF19 in an insulin‐independent manner.
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**Objective**: The ileum‐derived fibroblast growth factor 19 (FGF19) plays key roles in hepatic glucose homeostasis in animals in an insulin‐independent manner. Here, we analyzed the association of FGF19 with glucose effectiveness \[GE, the ability of glucose to enhance its own disposal and suppress hepatic glucose production (HGP) insulin independently\], as well as HGP in Chinese subjects.

**Methods**: GE was measured by frequently sampled intravenous glucose tolerance test (FSIVGTT) in 31 normal glucose tolerance (NGT), 34 isolated‐impaired glucose tolerance and 31 isolated‐impaired fasting glucose (I‐IFG) subjects. The oral glucose tolerance test‐derived surrogate of GE (oGE) was determined in 56 NGT, 23 I‐IFG, 36 combined glucose intolerance (CGI) and 83 type 2 diabetes (T2DM) subjects. HGP was assessed by labelled (\[3‐^3^H\]‐glucose) hyperinsulinemic‐euglycemic clamp in 14 NGT subjects. Insulin secretion and sensitivity were calculated by the hyperglycemic and hyperinsulinemic‐euglycemic clamps in a subgroup of 14 NGT subjects. Serum FGF19 levels were determined by ELISA.

**Results**: I‐IFG subjects (0.023 ± 0.001 min^−1^) had significantly lower GE than NGT subjects (0.029 ± 0.009 min^−1^) (*P* \< 0.05). However, no significant difference in GE was observed between I‐IGT (0.025 ± 0.01 min^−1^) and NGT subjects. Similar trend was also found in fasting serum FGF19 levels. FGF19 positively correlated with GE (r = 0.247, *P* = 0.015) as determined by FSIVGTT. The result was further confirmed by oGE (r = 0.261, *P* \< 0.001). Both FGF19 (r = −0.228, *P* = 0.025) and GE (r = −0.215, *P* = 0.035) were negatively associated with fasting plasma glucose (FPG), but the association between FGF19 and FPG no longer existed after adjusting for GE (r = −0.191, *P* = 0.064). FGF19 was negatively associated with basal HGP (r = −0.697, *P* = 0.006). However, the correlation between FGF19 and insulin secretion and sensitivity was not found.

**Conclusion**: FGF19 levels are associated positively with GE and negatively with HGP. The increase of FPG in human is at least partially due to the decrease of FGF19 in an insulin‐independent manner.
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Gymnemic acid‐I (GA‐I) and Gymnemic acid‐I (GA‐II) are the major active bioactive constituents of Gymnema sylvestre which has extensively been utilized in treating type 2 diabetes in traditional system of medicine since ancient times, however, mechanism of action of compounds yet to be defined. Using glide, the GA‐I and GA‐II compounds were docked to the active site of protein tyrosine phosphate 1B inhibitor from three‐dimensional structure of the enzyme complex (PDB ID: 1NL9) retrieved from protein data bank. Among two compounds, GA‐I has shown good docking score, based on molecular docking study report the silver nanoparticles synthesized using GA‐I and GA‐II compounds and tested for the therapeutic effect. The green synthesized nanoparticles were synthesized by using simple green synthesis method called centrifugation using silver nitrate and GA‐I and GA‐II under controlled temperature. The synthesized nanoparticles have been characterized for their morphology, crystalline nature, elemental analysis, size and functional group analysis. Characterization techniques used were SEM, HRTEM, XRD, EDAX and DLS. PTP 1B assay and streptozotocin‐induced diabetic animal model were carried out to determine the in vitro and in vivo anti hyperglycemic activity of AgNp, respectively. The GA‐I mediated AgNps shown excellent PTP 1B enzyme inhibitory activity among other compounds. The GA‐I mediated AgNp (100 mg/kg, 200 mg/kg), GA‐II mediated AgNp (100 mg/kg, 200 mg/kg) and metformin 50 mg/kg were administered to the diabetic rats. GA‐I mediated AgNp at dose level of 200 mg/kg (b.wt p.o.) showed significant inhibition of (*P* \< 0.001) blood glucose levels as compared with GA‐II mediated AgNp treated group. These detections revealed that GA‐I mediated AgNps possess potent antihyperglycemic and thus preferable over GA‐II mediated AgNp.
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**Purpose**: Ashitaba: Angelica keiskei is a perennial belonging to Umbelliferae, a Japanese native origin, widely native to Izu Oshima island, Japan. This study aimed to clarify the relationship among lifestyle habits related to Ashitaba, the dietary habits questionnaire (DHQ) and diabetic serum parameters of type 2 diabetes (T2DM).

**Method**: Among T2DM patients coming to Oshima Medical Center (OMC), for those who got the consent between February 5, 2018 and March 31, 2018, self‐administered survey was carried out. This study was a series of Ashitaba Study (UMIN000031141).

**Result**: There were 70 eligible subjects out of 106 subjects. They consisted of 47 males and 23 females, aged 69.1 ± 9.8 years old, BMI 25.2 ± 3.7 kg/m\^2, LDLc 109.7 ± 28.3 mg/dL, HDLc 54.2 ± 14.6 mg/dL, nonHDLc 137.2 ± 35.7 mg/dL, TG 145.9 ± 91.6 mg/dL and HbA1c 7.0 ± 0.8%. A total of 65 subjects had Ashitaba regularly, while Ashitaba consuming frequency was 5.3 ± 6.2 days/month. According to the result of DHQ, Understanding of Constitution and Body Weight (UCB) was 50.3 ± 16.4%, Food Choice Motive (FCM) was 39.2 ± 12.5%, Substitute Eating (SE) was 40.2 ± 11.5%, Hunger Satisfaction (HS) was 37.9 ± 12.1%, Eating Habit (EH) was 43.5 ± 17.4%, Dietary Content (DC) was 40.2 ± 11.9%, Regularity of Eating Habit (REH) was 39.9 ± 9.9%, Total Score (TS) was 40.2 ± 9.3%, which meant scores of UCB, FCM, SE, HS, DC were above previous reported normal‐weight group. The elderly aged 75 or over had Ashitaba frequently (7.08 ± 6.2/month vs 4.9 ± 6.1/month, *P* \< 0.05). In this group, UCB score was low (11.6 ± 4.1 vs 14.0 ± 4.2, *P* = 0.039), DC score was low (11.2 ± 2.9 vs 14.2 ± 4.4, *P* \< 0.05), TS was low (67.3 ± 13.0 vs 78.5 ± 17.9, *P* \< 0.05), and TG value was low (104.6 ± 53.5 vs 159.7 ± 97.3, *P* \< 0.05) ![](JDI-9-19-g001.jpg "image"). Ashitaba consuming frequency and HDLc showed correlation (α = 0.322, *P* \< 0.01).

**Conclusion**: T2DM patients coming to OMC were obese elderly groups with relatively good glycemic control. There is the possibility that TG value would be lower and HDLc value would be higher, if we approach to T2DM patients under 75 years with encouraging them to have Ashitaba more frequently and making effort to make their scores of DHQ low.
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**Purpose**: To develop a non‐invasive risk assessment tool and compare it to other screening risk assessment tools among middle‐aged and elderly Shanghainese.

**Method**: A population‐based sample of 15 309 individuals aged 45--70 years, without known diabetes, from a cross‐sectional survey in one of Shanghai\'s suburban areas was used here. The participants were randomly assigned to either the exploratory group or the validation group. Undiagnosed diabetes was defined according to the American Diabetes Association diagnostic criteria, and risk score points were generated according to the β‐coefficients.

**Result**: Age, family history of diabetes, hypertension, overweight/obesity, and central obesity all contributed to the constructed model, the Shanghai Nicheng Diabetes Risk Score, with the area under the receiver operating characteristic curve (AUC) being 0.654 (95% CI 0.637--0.670) in the exploratory group and 0.669 (95% CI 0.653--0.686) in the validation group. The score value of 6 was the optimal cut‐point with the largest Youden\'s index. When applied to the validation group, our model performed better than other risk scores for Asians, and had a similar discriminative ability to the New Chinese Diabetes Risk Score (AUC:0.669 vs. 0.662, *P* = 0.187). However, our model was inferior to fasting plasma glucose, 2‐hour plasma glucose, and glycosylated hemoglobin in detecting prevalent undiagnosed diabetes (AUC:0.669 (0.653--0.686) vs. 0.881 (0.868--0.894), 0.934 (0.923--0.944), and 0.834 (0.819--0.848), all *P* \< 0.001).

**Conclusions**: Although non‐invasive models, based on demographic and anthropometric information, are advisable in resource‐scarce developing areas, regular blood glucose screening is still necessary among those age 45 or older.
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**Introduction**: Hyperglycemia in critically ill patients is known to be associated with increased risk of morbidity and mortality. Conventional sliding scales for insulin infusion have been shown to be associated with delay in reaching target and increased risk of hypoglycemia and glycemic variability. In the year 2001, Dazzi et al applied fuzzy logic principles and neural network techniques to modify intravenous insulin administration. However, it became out of favor due to increased incidence of hypoglycemia. Since then, we have modified the regime to overcome the problem.

**Objective**: To evaluate the effectiveness and risk of hypoglycaemia of the Neuro‐Fuzzy Logic Algorithm (NFA) vs standard sliding scale insulin infusion in critically ill patients.

**Methods**: Sixty critically ill patients were randomly assigned to two insulin infusion regimes. In group A, insulin infusion rates were adjusted, every one to two hour based on a neuro‐fuzzy nomogram, and in group B, insulin infusion was adjusted according to conventional sliding scale.

**Results**: Initial Blood glucose (BG) levels were similar in the two groups (A: 15.22 ± 3.41 vs B: 15.5 ± 3.89 mmol/l: *P* = NS). In Group A, target BG was reached faster than in group B (4.16 ± 1.44 vs 8.3 ± 3.96 hours; *P* \< 0.0005). Mean BG was 9.04 ± 1.81 mmol/l in group A and 12.2 ± 3.3 mmol/l in group B, *P* \< 0.005. Mean insulin infusion rate for group A and B was 3.29 ± 1.12 vs 3.49 ± 0.86 U/hr, *P* = NS, at 4 hrs and 2.54 ± 0.92 vs 3.08 ± 0.78 U/hr, *P* \< 0.05, at 8 hours. Four patients experienced hypoglycemia in group A vs ten patients in group B.

**Conclusion**: The neuro‐fuzzy logic algorithm resulted in significantly rapid control of blood glucose levels albeit with less incidence of hypoglycemia. The neuro‐fuzzy method is superior because it takes into consideration the current as well as the previous blood glucose reading thus reducing marked variability in the insulin infusion rates.
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The recurrence of foot ulcer in patients with diabetes that leads to amputation is a tragedy for patients, health professionals, and the society. Understanding patients' self‐monitoring of foot health and relating factors of foot ulcer helps health professionals to enhance patients' awareness of the disease. This study investigated the behaviours of foot self‐monitoring in patients with DM and its relating factors. A descriptive correlational research design was adopted, and a self‐designed scale was used to investigate the patients' foot self‐monitoring knowledge, attitude, and actual behaviours. Purposive sampling was performed to recruit 100 patients. The collected data were analysed using *t* tests, *ANOVA*, Pearson\'s correlation, and hierarchical regression. The average score for the knowledge was 12.97 (SD = 4.90), with a total score of 19; thus, the correct rate was 68.26%. The average score of attitude was 49.63 (SD = 7.72), with a total score of 76. The average score of behaviour was 12.64 (SD = 9.68), which only reached 28.7% of the total score (44). The correlation coefficient for knowledge and behaviour was 0.20 and that for attitude and behaviour was 0.44. The hierarchical regression analysis indicated that the five predictor variables, namely overall foot self‐monitoring knowledge, overall foot self‐monitoring attitude, educational level (bachelor degree and higher), having received instructions regarding foot self‐monitoring, and having performed foot care, together explained 32.8% of the variance of the overall foot self‐monitoring behaviour. Moreover, the overall foot self‐monitoring knowledge and attitude explained 19.2% of the variance of the overall foot self‐monitoring behaviour. However, if the attitude variable was excluded, the explanatory power of the overall foot self‐monitoring knowledge for the behaviour was only 0.1% (F = 0.153, *P* \> 0.05). This study concluded that the patients seldom implement foot self‐monitoring behaviours. Thus, *Certified Diabetes Educator*s are suggested to evaluate patients' self‐monitoring ability in advance, examine whether they have difficulty in bending over due to obesity or have poor eyesight. In addition, the self‐monitoring knowledge and methods should still be emphasised in patient education, such as how to perceive symptoms of neurovascular foot lesions, method of monitoring pulsation, and innovative foot self‐monitoring devices.
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This abstract considers the encouragement of self‐management diabetes education for the overseas population, cultural beliefs and challenges they may have about their condition. This is an observational result from the point of a Credentialed Diabetes Educator. The Australian Bureau of Statistics, 2016 showed that more than a quarter (26%) of Australia\'s population (6,163,667 people) were born overseas.

Diabetes is the epidemic of the 21st century and the biggest challenge confronting Australia\'s health system.80 Australians develop diabetes every day. That is one person every five minutesAround 1.7 million Australians have diabetes. This includes all types of diagnosed diabetes (1.2 million known and registered) as well as silent, undiagnosed type 2 diabetes (up to 500,000 estimated)

Diabetes prevalence figures in Australia are primarily estimated from findings arising out of the National Health Survey conducted by the Australian Bureau of Statistics. The National Perinatal Data Collection estimates that 37,877 (6%) of women who gave birth between 2009--2011 were diagnosed with gestational diabetes. Diabetes is a chronic condition requiring the use of a variety of health services for its control and for the early diagnosis and treatment of associated complications. People with diabetes use a range of health services for support to reduce symptoms and the risk of complications, and to enhance their quality of life. GPs are usually the initial point of contact for people with diabetes and, along with other primary and allied health professionals, will commonly manage diabetes in collaborative care arrangements. Where diabetes complications arise, patients will be referred, as appropriate, to endocrinologists, cardiologists, nephrologists, obstetricians and/or ophthalmologists.

There are support management and treatment of diabetes such asThe Medicare Benefits Schedule, which provides subsidies for patient care and for the planning and management of chronic and terminal conditions.The National Diabetes Services Scheme -- managed by Diabetes Australia through an agreement with the Department of Health − provides subsidised products including syringes and needles, blood glucose test strips, urine ketone test strips and insulin pump consumables to persons with diagnosed diabetes who are registered with the Scheme.

**Conclusion**: People with diabetes, from the Asian and refugee background often lack knowledge about diabetes and self‐management of the disease due to difficulties in communication. The provision of diabetes education designed for the needs of this cohort is essential to improve the quality of life and life expectancy of these people.
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**Aim**: To determine whether patients joining diabetes self‐management programs have better glycemic control, quality of life and mental states than their regular care counterparts.

**Methods**: The non‐randomized control trial took place from January 2017 to March 2018 in local hospital in Sichuan Province, China. Type 2 diabetes patients with glycosylated hemoglobin (HbA1c) \>7.1 % at baseline formed the intervention group (63) and control group (61). According to the needs of patients, different program included healthy coping, self‐ care, healthy eating, exercises and insulin injection every month in the intervention group was provided. The programs were initiated by qualified diabetes educators, exercise prescription specialists and dieticians. Regular care was given to the control group per month: HbA1c, fasting plasma glucose (FPG), systolic and diastolic blood pressure (SBP, DBP), low‐density lipoprotein (LDL), body weight (BW), body mass index (BMI). Diabetes‐related emotional problem questionnaire (SF‐PAID‐8) and WHO‐5 Well‐being Index were collected both at pre‐ and post‐test. Statistical analyses were performed with SPSS version 12.0.

**Results**: Seventy‐seven (62%) participants were male. DM duration was 11.35 years (±6.29 years). Most patients were married (94%) and retired (84%). In the control group, pre‐test and post‐test in HbA1c, FPG, BP, BW and BMI results were insignificant. In the intervention group, changes in HbA1c (8.51% ± 1.25% to 7.76% ± 1.37, *P* \< 0.000), SBP (130.9 ± 19.2 mmHg to 126.4 ± 16.5 mmHg, *P* \< 0.05) and DBP (75.7 ± 11.2 mmHg to 72.32 ± 8.2 mmHg, *P* \< 0.05) were significant. Others exhibited insignificant fasting plasma glucose (FPG), BW and BMI . No significant differences between groups were found in SF‐PAID and WHO‐5 at pre‐test. Using a WHO‐5 cut‐off of \<13, 10% of intervention group and 15% of control group were at risk for depressed mood. The post‐test score (9.51 ± 3.4) of the SF‐PAID‐8 was higher than pre‐test (7.79 ± 8.3), *P* \< 0.000 and WHO‐5 score was 18.72 ± 5.2 which was significantly lower than pre‐test 19.57 ± 5.5, *P* \< 0.007 in the control group. The patients in the intervention group proved insignificant in both SF‐PAID‐8 and WHO‐5.

**Conclusion**: This study found that diabetes self‐management intervention program, might improve HbA1c value, and decrease diabetes‐related emotional problems. Further studies will be conducted on patients who are at risk of depression.
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**Introduction**: The prevalence of type 2 diabetes patients is steadily increasing in Cambodia. It is a huge burden for the society. Despite considerable advances in the management of diabetes, there is still a large gap between treatment goals and actual outcomes. Lack of knowledge, wrong attitudes and malpractice among both healthcare providers and patients regarding diabetes may play a very important role in failure to achieve therapeutic goals.

**Objectives**: The aim of this study was to evaluate the level of knowledge, attitude and practice regarding diabetes of Cambodian medical student and patients.

**Materials and methods**: This was a cross‐sectional study conducted at the University of Health Sciences and three healthcare settings in Cambodia. Face‐to‐face interviews were held to fill questionnaire. The questionnaire was developed and validated by local experts for patients and later modified the some forms to interview medical students. We divided the participants in to three group groups (T2D patients with hemodialysis, T2D patients without dialysis and medical students). The data was analyzed by using STATA 13.1.

**Results**: In the group T2D with dialysis, 59 patients (29 females) from two public hemodialysis centers with the mean age of 63.9 (±7.4) were enrolled. In the group T2D without dialysis, 139 patients (92 females) from one public hospital and one private center with the mean age of 57.9 (±12.1) were enrolled. And in the group medical students, 189 medical students (119 females) from the university of health science with mean age 23.9 (±0.9) participated in the study. As the result we found that in the group T2D with dialysis the KAP score was low while in the group T2D without dialysis the KAP score was moderate. However in the group medical students, the KAP score was high.

**Conclusion**: This study found that the knowledge, attitude and practice regarding diabetes among Cambodian type 2 diabetic patients were moderately low. Nevertheless, the KAP score was high among future healthcare providers. More understandable educational materials should be created for the patients.
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**Objective**: Inadequate knowledge about diabetes in rural Indian settings leads to under‐diagnosis of diabetes and sub‐optimal diabetes control. Project Diabetes with Dignity (DWD) aimed to test the feasibility and effectiveness of a model of enhanced diabetes care through empowerment of Accredited Social Health Activists (ASHA; community health workers), in a rural Indian setting.

**Methods**: DWD was conducted with 416 adults (30--70 years) with diabetes in Baramati, Pune district, over a study duration of one year. Intervention area included all villages under two sub‐centres of one Primary Health Centre (PHC) in Baramati. Control area included all villages under three sub‐centres of another PHC in Baramati. ASHAs screened all adults for diabetes, and implemented the six month DWD intervention (counselling patients/family; monthly house‐to‐house visits; community awareness‐raising) in the intervention area. Difference in changes in knowledge about diabetes, symptoms, management and complications, and Quality of Life (QoL) between patients with diabetes in intervention vs. control areas, from baseline to end‐line, was assessed using a questionnaire and analyzed via mixed‐effects regression model. Confounding factors, including age, socioeconomic status, gender, duration of diabetes, and tobacco/alcohol use, were adjusted in the models.

**Results**: About 52% patients belonged to the intervention group. There was a significant increase in knowledge about diagnosis/management among patients in the intervention group \[31.48% (95% CI 24.52--38.43) to 59.55% (95% CI 52.52--66.58)\] compared to a decline in the control group \[40.73% (95% CI 33.40--48.07) to 27.95% (95% CI 19.40--34.50)\] (*P* \< 0.001). Similar improvements in the intervention group were observed for knowledge about symptoms and complications of diabetes. For QoL, the percentage of patients having some problems in self‐care showed a higher decline in the intervention group (29.46% to 6.98%) vs. the control group (4.85% to 3.55%) (*P* = 0.005). Reduction in anxiety/depression was significant in the intervention vs. control group (*P* \< 0.001).

**Conclusion**: DWD was effective in improving QoL and knowledge about diabetes. Capacity‐building of ASHAs for prevention and management of diabetes in rural settings is recommended. Support: The project was funded by Sanofi India Ltd. as part of its public health initiatives for prevention and management of Diabetes.
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**Objectives**: Healthy eating habit is important for the prevention of lifestyle‐related disease such as diabetes.

It is important that children learn to eat a healthy and varied diet from an early age, because it is difficult to change eating habits in adulthood. Food neophobia, the dislike of new foods, is typical in children of about 2--3 years of age. On the other hand, active familiarization with new food can be promoted by using all senses on 2--3 years of age. In some European countries, sensory‐based food education named Sapere method is introduced to reduce food neophobia and promote healthy diet. We have developed a series of sensory‐based food education for 2--3 years old children firstly in Japan with using Sapere method. Aim of this study is evaluate an effectiveness of this method by changing of children\'s eating behavior.

**Methods**: Participants were 41 children aged 2 (*n* = 18) and 3 (*n* = 23) at a nursery school in Kyoto, Japan. At the nursery school, a series of sensory‐based food education (6 lessons) were conducted from May to October 2017. The parents were asked about children\'s eating behaviour by questionnaire before and after conducting lessons.

**Results**: Parents of 16 children aged 2 and 15 children aged 3 answered questionnaire about their children. The response rate of the questionnaire was 76%. Concerning to change of children\'s eating behaviour after intervention, 74.2% of children (87.5% of 2 yrs, 60.0% of 3 yrs.) increased their interests about food and meal, 61.3% of children (50.0% of 2 yrs, 73.3% of 3 yrs.) became to eager to assist meal preparation at home and 25.8% of children (37.5% of 2 yrs, 13.3% of 3 yrs.) reduced number of their dislike foods. 87.1% (81.3% of 2 yrs, 93.3% of 3 yrs) of children enjoyed the series of sensory‐based food education and all parents showed their wishes to continue of this education.

**Conclusion**: The sensory‐based food education seems to be welcomed by the children, and it may reduce food neophobia and promote healthy diet.
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**Background and aims**: Overweight or obese persons have an increased risk of developing diabetes. Nutritional therapy is important for self‐management of body weight. In recent years, low‐carbohydrate diets have attracted considerable attention and several weight loss trials have shown that such diets are more effective than diets with a higher carbohydrate content. Though low‐carbohydrate diets can achieve weight loss, there is concern that muscle mass may also decrease. We hypothesized that replacement of dietary carbohydrate with a protein supplement would prevent a decrease of muscle mass in persons on a low‐carbohydrate diet.

**Materials and methods**: In 2017--2018, a 24‐week prospective randomized open‐label study was performed at a single center to evaluate the effects on body composition when dietary carbohydrate was replaced by a protein supplement. A total of 20 overweight Japanese subjects (BMI \> 25.0) were randomly assigned to two groups: 10 were instructed to continue a diet with 55--60% carbohydrate (group C), while the other 10 were instructed to restrict dietary carbohydrate to 10--15% of the total energy requirement and replace the rest with a soy protein supplement (group P). Whole and regional body composition parameters were measured by dual‐energy X‐ray absorptiometry. The appendicular skeletal muscle index (ASMI) was calculated as follows: lean mass of the limbs (arms and legs) /square of the height (kg/m^2^).

**Results**: At baseline, body weight was 75.8 ± 10.3 kg (mean ± SD) in group C and 77.6 ± 11.0 kg in group P. The other clinical characteristics of the two groups were also well balanced. After 24 weeks, the body weight was 72.4 ± 9.7 kg and 69.6 ± 10.8 kg, respectively, showing greater reduction in group P (adjusted mean difference: −4.6 kg \[95% CI −8.1 to −1.1\]). Body composition analysis revealed a significant decrease of ASMI in group P (adjusted mean difference: −0.79 kg/m^2^ \[95% CI: −1.45 to −0.13\]). During the study period, no adverse effects were noted in either group, including deterioration of renal function.

**Conclusion**: Replacement of dietary carbohydrate with a protein supplement for 24 weeks achieved greater weight loss. However, desirable weight reduction involving preferential fat loss with less muscle loss was not confirmed.
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**Introduction**: Diabetes is on an increase in Asia. Health literacy and knowledge are key factors associated with improved clinical outcomes in diabetes. However, few studies have explored diabetes specific literacy and knowledge in Asian patients. The aim of this study was to investigate diabetes specific literacy and knowledge levels among Malaysian adults with Type 2 Diabetes mellitus (T2DM).

**Methods**: A cross‐sectional study was conducted among T2DM patients aged 18 and above attending a public primary health clinic in Seremban, Malaysia. Diabetes literacy was assessed using the Literacy Assessment for Diabetes questionnaire, and the 14‐item Michigan Diabetes Knowledge Test was administered to assess diabetes knowledge. Participants' recent HbA1c values to assess glycaemic control were obtained from medical records.

**Results**: A total of 196 adults participated in this study. The majority of respondents were middle‐aged adults (95.9%), women (56.1%), educated up till secondary school level (61.2%), obese with BMI ≥27.6 kg/m^2^ (58.2%), and had poor glycaemic control with HbA1c \> 7% (75.5%). Although 75.0% had diabetes literacy scores corresponding to secondary education, the mean diabetes knowledge score was poor (6.8 ± 2.6 points out of a maximum of 14 points). Diabetes literacy was significantly associated with diabetes knowledge (Pearson\'s r = 0.445, *P* \< 0.01), with the former explaining up to 19.8% of the variance in the latter. Ethnicity and education level were associated with diabetes literacy and knowledge. Item analysis of diabetes knowledge constructs showed that between 53.0% and 66.8% of patients correctly answered questions on general knowledge of healthy eating for diabetes, diabetes self‐care practice, effect of exercise on blood glucose, and complications related to poorly controlled diabetes. However for specific questions on food groups and the effect of diet on sugar control, correct answers were only 23.0% and 49.0%, respectively.

**Conclusion**: Adult T2DM patients in this primary care clinic had fairly good diabetes specific literacy scores to process health information. Their diabetes knowledge scores, however, indicated a need for patient interventions that include nutrition specific education.
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**Introduction**: Lifestyles, especially eating habits, play a key role in the development and progression of chronic non‐communicable diseases. It is also an important measure for prevention and treatment.

**Aim**: To explore whether different staple food types were associated with overweight, obesity, diabetes and hypertension risk in China.

**Methodology**: A total of 46,239 people were enrolled in the study of diabetes mellitus and metabolic disorders in China from 2007 to 2008. According to the self‐reported main staple food information (average consumption no \<3 times a week), the residents will be divided into rice type, mixed type and wheat type diet. The relationship between different staple food patterns and overweight, obesity, diabetes mellitus and hypertension was analyzed by the binary logistic analysis. The odds ratio (OR) and 95% confidence interval (95% CI) were calculated by stepwise regression method. Among the three staple food patterns, the rice diet was used as the reference group, and the gender, age, staple intake, occupation, family income, physical exercise and diet control were corrected in the analysis.

**Results**: For the whole population, mixed type diet and wheat type diet increase the risk of overweight (OR = 1.31, 95% CI: 1.26--1.37, *P* \< 0.001; OR = 1.43, 95% CI: 1.34--1.52, *P* \< 0.001); mixed type diet and wheat type diet also increased the risk of obesity (OR = 1.60, 95% CI: 1.49--1.71, *P* \< 0.001; OR = 1.74, 95% CI: 1.58--1.90, *P* \< 0.001); for diabetes (OR = 1.11, 95% CI: 1.03--1.20, *P* = 0.007; OR = 1.11, 95% CI: 1.00--1.23, *P* = 0.048); for hypertension (OR = 1.09, 95% CI: 1.03--1.15, *P* = 0.002; OR = 1.25, 95% CI: 1.16--1.34, *P* \< 0.001). In addition, positive significant association was also found in Beijing, Liaoning, Shanxi, Hunan, Jiangsu, Shanghai and Xinjiang. In different provinces, the relationship between staple food type and disease risk was different, or even opposite.

**Conclusion**: Different tactics should be taken to adjust people\'s eating habits for better prevention and treatment of these chronic diseases.
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**Background**: Various hormonal therapies have been formulated to combat the cardiovascular disease (CVD) risks in postmenopausal women, but the beneficial effects have not been consistent. Elevated glycogen synthase kinase‐3 (GSK‐3) has been associated with abnormal cardiometabolic effects. Spironolactone is a well‐known antagonist of mineralocorticoid receptor.

**Objectives**: We therefore tested the hypothesis that estrogen deprivation will cause obese‐insulin resistance and elevated GSK‐3 that would be accompanied by increased mineralocorticoid and glucocorticoid. We also aimed at testing the hypothesis that low‐dose spironolactone would ameliorate these abnormalities by replenishing estrogen and suppressing mineralocorticoid/glucocorticoid/GSK‐3 pathway.

**Methods**: Ten weeks old female Wistar rats were divided into four groups; sham‐operated (SHM), spironolactone (SPL; 0.25 mg/kg) and ovariectomized (OVX) rats treated with or without spironolactone daily for 8 weeks after which analyses were done.

**Results**: The results indicate that estrogen deprivation through ovariectomy caused obesity with insulin resistance (IR) that is accompanied by increased pancreatic‐β cell dysfunction, glucose intolerance, platelet/lymphocyte ratio, hyperinsulinemia, atherogenic dyslipidemia, GSK‐3, corticosterone, aldosterone and depressed 17β‐estradiol. Treatment with spironolactone reversed all these abnormalities.

**Conclusion**: Low‐dose spironolactone improves obesity and IR, which appears to involve replenishment of estrogen and suppression of GSK‐3 along with circulating mineralocorticoids and glucocorticoids. Therefore, spironolactone may be an adjuvant pharmacological therapy for cardiometabolic disorder induced by estrogen deprivation
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The purpose of the study: Visceral fat is known to predict the development of metabolic syndrome (MetS), but it is not known whether the visceral‐to‐subcutaneous fat area ratio (VSR) measured using imaging predicts MetS risk. Thus, we aimed to examine if VSR predicted future risk of MetS over a 10‐year follow‐up.

**Methods**: Data were acquired from the longitudinal Japanese‐American Community Diabetes Study, and we used the modified ATP III MetS criteria for an Asian population to classify participants as to presence of MetS. We followed participants without MetS at baseline (*n* = 313) for its development over 10 years. Intra‐abdominal and abdominal subcutaneous fat areas at the level of the umbilicus were measured by CT at baseline and 10‐year follow‐up. Other measurements included fasting glucose, serum HDL‐cholesterol and triglyceride concentrations, systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), and body mass index (BMI). Logistic regression analysis was used to estimate the odd ratio of incident MetS by VSR, 10‐year VSR change and baseline MetS features.

**Results**: Of the 313 participants, 87 progressed and 226 did not progress to MetS over 10‐years. Multivariable logistic regression models showed a higher odds of incident MetS with 1‐SD greater VSR (OR = 1.74; 95% CI = 1.19--2.53; *P* = 0.004) and 1‐SD greater VSR change (OR = 1.45; 95% CI = 1.07--1.97; *P* = 0.018) adjusting for age, sex, and 10‐year VSR change. Additional adjustment for WC and BMI showed a similar result for VSR and VSR change (VSR OR = 2.01; 95% CI = 1.34--3.02; VSR change OR = 1.64; 95% CI 1.17--2.29) as did further adjustment for other MetS features at baseline (fasting glucose, triglycerides, HDL‐cholesterol, and SBP and DBP) (VSR OR = 1.66; 95% CI = 1.09--2.55; VSR change OR = 1.42; 95% CI 0.99--2.02), although VSR change became borderline significant.

**Conclusions**: VSR predicts 10‐year follow‐up MetS risk in Japanese Americans, confirming the importance of relatively greater fat distribution in the visceral depot in the development of MetS. Further research is needed to confirm this association in other populations.
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**Background**: To examine the relationship between serum uric acid levels (SUA) reduction and changes in sex hormones after laparoscopic sleeve gastrectomy (LSG) in Chinese obese male patients.

**Methods**: A total of 56 obese men with body mass index (BMI) 38.03 ± 4.71 kg/m^2^ undergoing LSG between June 2012 and March 2018 were selected. A total of 31 healthy men with normal BMI were included as controls. Levels of SUA, total testosterone (TT), estradiol (E2), sex hormone binding‐globulin (SHBG), follicle‐stimulating hormone (FSH), luteinizing hormone (LH) and other metabolic indices were measured at baseline and the 3rd, 6th, and 12th months post LSG. Calculated free testosterone (cFT) was calculated from TT and SHBG using an empirical equation.

**Results**: At baseline, hyperuricemia (HUA) and low total testosterone (TT) were common in obese men. After LSG, statistically significant reduction in weight, BMI, and glucolipid metabolism indices were noted at 3, 6, and 12 months from baseline values (all *P* \< 0.05). SUA and prevalence of HUA declined remarkably from 474.85 ± 94.56 μmol/L to 338.76 ± 81.92 μmol/L and from 76.8% to 54.1% at 12 months postsurgery from baseline (*P* \< 0.001, *P* \< 0.01, respectively). Additionally, TT, SHBG, and cFT increased significantly at 3, 6, and 12 months after LSG (*P* \< 0.05), while E2, FSH, and LH did not change much post LSG. Moreover, the change (Δ) in SUA levels at 12 months after LSG was positively associated with ΔBMI, ΔFINS, ΔHOMA‐IR and negatively associated with ΔTT, ΔSHBG, and ΔcFT (all *P* \< 0.001). After adjusting age and BMI, the reduction in SUA correlated significantly with increased TT (*β *= −1.077, *P* = 0.044), SHBG (*β *= −0.258, *P* = 0.041) and decreased FINS (*β *= 1.381 *P* = 0.010).

**Conclusions**: LSG appears to improve HUA and hormonal imbalance. Reduced SUA after surgery may mediated by increased TT, SHBG and improved insulin resistance at 12 months after surgery.
